Retinal vascular occlusion

H7_RETIVASCOCCLUSION

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H34 Cause of death: ICD-10 — H34 2 out of 7 registries used, show all original rules.	5846
4. Check minimum number of events None	5846
5. Include endpoints None	5846
6. Filter based on genotype QC (FinnGen only)	5211

Control definitions (FinnGen only)

Control exclude: H7_CHOROIDRETINA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H30-H36
Name in latin: Occlusiones vasculares retinae

NAME	H7_RETIVASCOCCLUSION
CONTROL_EXCLUDE	H7_CHOROIDRETINA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H34
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H34
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Retinal vascular occlusion based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Transient retinal artery occlusion

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37188	18641	18366
Only index persons	34152	17322	16830
Unadjusted period prevalence (%)
Whole population	0.52	0.53	0.51
Only index persons	0.64	0.64	0.64
Median age at first event (years)
Whole population	72.34	74.37	70.25
Only index persons	71.86	73.87	69.79

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5211	2399	2812
Unadjusted period prevalence (%)	1.09	0.85	1.29
Median age at first event (years)	70.57	70.23	70.85

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5370: Matched controls
53700

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

114

Kela drug reimbursment

Glaucoma

3.9

314.8

1126

3451

H33.3

ICD-10 Finland

Retinal breaks without detachment

158.5

310.3

154

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

14.0

307.7

1183

1063

CK9F4

NOMESCO Finland

Fluorescein angiography (FAG) of choroid and retina

146.3

307.7

170

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.9

307.7

1577

5220

S01ED51

ATC

timolol, combinations; ophthalmic

5.2

307.7

1129

2615

H43.1

ICD-10 Finland

Vitreous haemorrhage

23.2

307.7

458

215

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

568.8

307.7

1836

XCW99

NOMESCO Finland

Other investigative procedure of eye

8.0

307.7

1455

2373

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

108.0

307.7

267

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

35.4

307.7

370

112

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

49.5

307.7

295

CKC12

NOMESCO Finland

Photocoagulation of retina

216.9

307.7

977

CKC10

NOMESCO Finland

Local photocoagulation of retina

102.4

307.7

263

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

17.9

307.7

434

262

H34.1

ICD-10 Finland

Central retinal artery occlusion

2304.5

307.7

832

H34.2

ICD-10 Finland

Other retinal artery occlusions

2410.1

307.7

863

CKC15

NOMESCO Finland

Panretinal photocoagulation

167.3

307.7

178

H35.31

ICD-10 Finland

Senile macular degeneration (atrophic)(exudative)

108.1

307.7

536

XCD20

NOMESCO Finland

Photoangiography of eye

112.9

307.7

455

XCK10

NOMESCO Finland

Photography of fundus of eye

6.2

307.7

1239

2478

Z96.1

ICD-10 Finland

Presence of intraocular lens

3.6

307.7

1493

5171

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

12.7

307.7

1619

1759

XCH00

NOMESCO Finland

Eye pressure measurement

6.5

307.7

619

1059

H34.8

ICD-10 Finland

Other retinal vascular occlusions

7318.1

307.7

3929

WX140

NOMESCO Finland

Parabulbar anesthesy

9.4

307.7

490

566

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

22.5

288.0

212

XCK00

NOMESCO Finland

Perimetry

4.6

282.7

740

1793

S01EE01

ATC

latanoprost; ophthalmic

4.1

265.8

824

2266

H34.9

ICD-10 Finland

Retinal vascular occlusion, unspecified

447.1

258.7

257

S01EA05

ATC

brimonidine; ophthalmic

6.8

257.5

424

673

S01EC01

ATC

acetazolamide; systemic

7.8

240.2

344

468

ZX198

NOMESCO Finland

Other local administration

24.5

238.1

169

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

4.2

203.4

592

1542

H36.01

ICD-10 Finland

Diabetic maculopathy

89.2

199.8

105

CHF05

NOMESCO Finland

Transscleral laser coagulation of ciliary body

20.8

195.3

148

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

91.7

189.0

S01EC04

ATC

brinzolamide; ophthalmic

4.3

188.4

516

1282

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

62.4

187.7

104

H36.00

ICD-10 Finland

Diabetic background retinopathy

51.4

175.8

101

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.2

171.1

2678

16692

H33.0

ICD-10 Finland

Retinal detachment with retinal break

299.7

170.9

173

H53.9

ICD-10 Finland

Visual disturbance, unspecified

5.1

169.7

377

789

H3601, E113,

ICD-10 Finland

+∞

161.2

154

CK2M4

NOMESCO Finland

Macular light layer imaging (OCT)

18.8

160.4

127

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

39.8

154.4

CKW99

NOMESCO Finland

Other operation on choroid, vitreous body and retina

519.2

153.5

152

H25.1

ICD-10 Finland

Senile nuclear cataract

2.1

149.4

2312

14127

CM2X4

NOMESCO Finland

Follow-up OCT of age-related macular degeneration lesions

68.5

148.4

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

5.2

147.8

316

639

H53.1

ICD-10 Finland

Subjective visual disturbances

3.5

147.5

548

1679

XCW10

NOMESCO Finland

Assessment of vision

8.0

144.7

199

257

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

23.0

143.3

104

S01EC54

ATC

brinzolamide, combinations; ophthalmic

6.9

137.5

216

324

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.0

133.8

2282

14292

CKD40

NOMESCO Finland

Endophotocoagulation of retina

275.7

131.8

134

S01EA03

ATC

apraclonidine; ophthalmic

10.7

131.5

144

138

AA1AD

NOMESCO Finland

CT of head and brain

2.0

128.7

2163

13425

H54.4

ICD-10 Finland

Blindness, monocular

28.2

127.6

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.3

125.8

527

1735

H3600, E113,

ICD-10 Finland

+∞

125.5

120

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

5.5

124.2

245

460

H40.0

ICD-10 Finland

Glaucoma suspect

2.9

124.2

664

2513

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

4.5

123.6

317

744

S01ED01

ATC

timolol; ophthalmic

3.9

122.8

384

1044

H43.8

ICD-10 Finland

Other disorders of vitreous body

2.8

122.6

668

2553

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.7

120.5

745

3039

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

119.4

2636

17830

ZXA10

NOMESCO Finland

Bilateral

2.2

119.0

1255

6504

CS494

NOMESCO Finland

Other visual field testing

4.9

118.3

272

584

B01AC04

ATC

clopidogrel; oral

2.1

115.3

1408

7715

CKC20

NOMESCO Finland

Cryopexy of undetached retina

169.3

110.7

116

H26.4

ICD-10 Finland

After-cataract

2.4

109.5

847

3833

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

228.7

109.1

112

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

28.5

108.6

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

38.1

103.8

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

3.8

103.6

325

884

I10

ICD-10 Finland

Essential (primary) hypertension

2.0

101.8

3975

31659

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

5.2

98.0

206

409

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.5

97.7

362

1100

Z5132

NOMESCO Finland

Nursing associate professional

12.7

96.6

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

148.5

96.4

102

H35.8

ICD-10 Finland

Other specified retinal disorders

195.4

92.6

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

3.5

90.5

330

992

H33.5

ICD-10 Finland

Other retinal detachments

17.7

86.1

H53.4

ICD-10 Finland

Visual field defects

4.5

85.6

213

487

C08CA01

ATC

amlodipine; oral

1.7

84.6

2597

18736

G45.3

ICD-10 Finland

Amaurosis fugax

4.3

84.6

223

533

S01EE05

ATC

tafluprost; ophthalmic

3.3

84.4

340

1087

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

6.4

83.1

138

219

H34.0

ICD-10 Finland

Transient retinal artery occlusion

821.0

82.7

S01EC03

ATC

dorzolamide; ophthalmic

4.8

82.7

189

403

H35.6

ICD-10 Finland

Retinal haemorrhage

215.9

82.6

H3603, E113,

ICD-10 Finland

+∞

82.5

C10AA05

ATC

atorvastatin; oral

1.7

82.0

2731

20092

PA6AD

NOMESCO Finland

CT of neck arteries

3.3

79.7

317

1005

S01EE03

ATC

bimatoprost; ophthalmic

3.9

78.8

242

647

S01EX03, ,

ATC

3.9

77.3

233

615

CA1AE

NOMESCO Finland

Eye and orbita ultrasound examination

13.5

76.7

1LA05, ,

NOMESCO Finland

+∞

74.1

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

14.2

72.4

H35.36

ICD-10 Finland

Macular cyst

362.1

71.8

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.4

69.6

545

2453

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.0

69.3

951

5316

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

69.0

2919

22467

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

11.4

68.2

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.2

68.0

186

457

H21.1

ICD-10 Finland

Other vascular disorders of iris and ciliary body

92.6

66.0

CHF15

NOMESCO Finland

Cryotherapy of ciliary body

81.2

64.1

H35.37

ICD-10 Finland

Macular holes

169.6

64.1

H40.9

ICD-10 Finland

Glaucoma, unspecified

3.8

63.5

198

535

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

62.6

557

2643

H35.9

ICD-10 Finland

Retinal disorder, unspecified

28.2

62.2

S01EE04

ATC

travoprost; ophthalmic

3.6

62.0

206

581

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

7.2

60.9

126

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

7.4

59.7

120

PAN14

NOMESCO Finland

Plastic repair of arteries internal carotid artery

6.4

59.3

158

F05

ICPC

Visual disturbance other

3.3

58.9

231

725

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

3.5

58.7

211

627

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

574.3

57.8

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

8.2

57.2

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

3.7

56.9

181

496

H25.8

ICD-10 Finland

Other senile cataract

1.9

54.8

841

4845

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.9

54.6

168

ZXA05

NOMESCO Finland

Left side

1.7

54.6

1425

9559

N02BE01

ATC

paracetamol; systemic, rectal

1.9

54.1

4722

42398

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

53.9

1419

9534

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

52.4

708

3910

Z3231

NOMESCO Finland

Registered nurse

1.6

52.3

1506

10339

H3603, E103,

ICD-10 Finland

+∞

52.2

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

51.2

389

1722

C10AA01

ATC

simvastatin; oral

1.5

51.1

2750

21759

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

8.1

49.5

C03CA01

ATC

furosemide; systemic

1.5

49.4

2252

17140

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.0

49.2

222

757

ZXA00

NOMESCO Finland

Right side

1.6

48.5

1514

10565

H25.0

ICD-10 Finland

Senile incipient cataract

2.1

47.1

453

2208

H35.7

ICD-10 Finland

Separation of retinal layers

+∞

46.9

WX142

NOMESCO Finland

Sub-tenon anesthesy

8.5

45.9

A10AB05

ATC

insulin aspart; parenteral

2.2

45.8

427

2055

S01BC03

ATC

diclofenac; ophthalmic

3.6

45.7

152

429

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.2

45.3

184

590

H3601, E103,

ICD-10 Finland

+∞

44.8

C07AB07

ATC

bisoprolol; oral

1.5

44.8

3010

24663

H54.5

ICD-10 Finland

Severe visual impairment, monocular

7.9

43.8

A98

ICPC

Health maint/preventive medicine

1.9

43.0

4822

44212

H3600, E103,

ICD-10 Finland

+∞

42.8

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

42.0

1425

10076

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

41.4

1346

9419

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

40.9

725

4336

C08CA13

ATC

lercanidipine; oral

1.7

40.7

933

5990

F29

ICPC

Eye symptom/complaint other

1.9

40.2

539

2956

A10AE04

ATC

insulin glargine; parenteral

1.9

40.0

530

2894

CK2K4

NOMESCO Finland

Red-free imaging of ocular fundus

58.0

39.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

39.1

1081

7270

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.1

38.9

T90

ICPC

Diabetes non-insulin dependent

1.5

38.4

1412

10128

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

38.2

1564

11474

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

38.1

1139

7794

CHD00

NOMESCO Finland

Laser trabeculoplasty

3.7

38.0

119

323

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

37.8

516

2845

A10AA01, ,

ATC

4.5

37.7

203

SPAT1263

SPAT

Sampling

1.5

37.7

2111

16479

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

37.4

1698

12713

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

37.2

1599

11836

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.2

36.6

150

484

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

14.4

36.5

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

35.9

274

1213

CKD15

NOMESCO Finland

Injection of vitreous substitute

186.2

35.8

S01BC05

ATC

ketorolac; ophthalmic

2.4

35.8

262

1139

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

35.6

3269

27853

A10AB01

ATC

insulin (human); parenteral

3.3

34.5

131

403

A10AC01

ATC

insulin (human); parenteral

2.0

33.9

381

1964

A11CC03

ATC

alfacalcidol; systemic

2.9

33.3

160

565

205

Kela drug reimbursment

Chronic hypertension

1.4

33.3

1787

13750

WX002

NOMESCO Finland

Sedation and analgesia

1.6

33.3

1016

6961

H20.1

ICD-10 Finland

Chronic iridocyclitis

5.5

33.1

118

A10AE05

ATC

insulin detemir; parenteral

2.2

33.0

272

1244

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

32.7

559

3296

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

171.1

32.7

C09AA05

ATC

ramipril; oral

1.5

32.6

1575

11867

A02BC02

ATC

pantoprazole; systemic

1.4

32.5

3551

30958

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

8.9

32.4

H40.11

ICD-10 Finland

Low pressure glaucoma

2.8

32.4

167

613

CHD99

NOMESCO Finland

Other filtering operation

9.8

32.1

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

62.1

32.0

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

31.9

743

4767

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

31.7

484

2760

J01DB01

ATC

cefalexin; oral

1.5

31.5

4065

36427

127

Kela drug reimbursment

Transplant complication

4.2

31.4

199

CK9G4

NOMESCO Finland

Iridocyanine green angiography (ICGA) of choroid and retina

314.7

30.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

30.8

421

2318

CKD20

NOMESCO Finland

Removal of vitreous body substitute

160.9

30.7

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

30.7

1469

11025

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

30.6

1434

10715

H53.8

ICD-10 Finland

Other visual disturbances

3.8

30.2

245

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

58.7

30.1

H47.1

ICD-10 Finland

Papilloedema, unspecified

6.9

30.1

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

4.3

30.0

185

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

29.8

1174

8470

S01ED02

ATC

betaxolol; ophthalmic

3.8

29.7

248

T89

ICPC

Diabetes insulin dependent

2.8

29.6

147

529

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

29.6

1549

11807

L28

ICPC

Limited function/disability (L)

1.5

29.3

1213

8839

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

28.8

151

559

H21.0

ICD-10 Finland

Hyphaema

7.2

28.4

S18

ICPC

Laceration/cut

1.4

28.3

2451

20320

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.2

28.3

254

1202

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

28.1

1441

10921

R53

ICD-10 Finland

Malaise and fatigue

1.5

28.0

1306

9723

A10AA02, ,

ATC

2.9

28.0

130

451

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

28.0

147

545

R06.0

ICD-10 Finland

Dyspnoea

1.4

27.8

1506

11521

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

4.1

27.6

184

H04AA01

ATC

glucagon; nasal, parenteral

4.7

27.5

135

C01DA14

ATC

isosorbide mononitrate; oral

1.5

27.3

1145

8347

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.9

27.3

212

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.1

27.0

256

1237

C02AC05

ATC

moxonidine; oral

2.0

27.0

294

1496

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

26.7

381

2123

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

26.4

538

3326

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.6

26.3

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.9

26.2

117

C10AX09

ATC

ezetimibe; oral

1.5

26.0

899

6295

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

25.9

1538

11928

J01CA04

ATC

amoxicillin; systemic

1.4

25.8

3835

34430

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

25.7

1506

11653

C09CA01

ATC

losartan; oral

1.4

25.7

1442

11075

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.6

25.6

135

R42

ICD-10 Finland

Dizziness and giddiness

1.4

25.1

1300

9835

L04AD02

ATC

tacrolimus; systemic

5.0

25.1

106

H02AB06

ATC

prednisolone; systemic

1.4

24.9

2407

20153

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

70.2

24.8

M79.6

ICD-10 Finland

Pain in limb

1.4

24.8

2030

16568

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

24.7

550

3477

C08CA02

ATC

felodipine; oral

1.6

24.5

617

4019

A10BA02

ATC

metformin; oral

1.4

24.4

1585

12458

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

5.5

24.1

A10AB04

ATC

insulin lispro; parenteral

3.0

24.1

105

352

H57.1

ICD-10 Finland

Ocular pain

2.4

24.0

163

685

S97

ICPC

Chronic ulcer skin

1.8

24.0

396

2305

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

23.9

793

5495

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

23.8

1090

8055

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

23.7

1038

7603

H26.2

ICD-10 Finland

Complicated cataract

4.4

23.6

136

B01AA03

ATC

warfarin; systemic

1.4

23.1

1310

10047

L17

ICPC

Foot/toe symptom/complaint

1.4

23.1

1489

11667

A10AE06

ATC

insulin degludec; parenteral

2.5

22.9

144

584

137

Kela drug reimbursment

Uraemia requiring dialysis

4.5

22.8

123

L04AA06

ATC

mycophenolic acid; systemic

3.1

22.8

310

H35.4

ICD-10 Finland

Peripheral retinal degeneration

40.2

22.6

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

22.6

266

1391

H47.2

ICD-10 Finland

Optic atrophy

6.4

22.6

CK2Y4

NOMESCO Finland

OCT video recording of ocular fundus

120.5

22.6

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

22.5

1172

8851

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

22.5

1484

11663

A46

ICD-10 Finland

Erysipelas

1.5

22.4

849

6039

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

22.3

1229

9368

TK800

NOMESCO Finland

Hemodialysis

2.7

22.3

124

474

Z71.8

ICD-10 Finland

Other specified counselling

1.4

22.2

1449

11359

Z94.0

ICD-10 Finland

Kidney transplant status

4.3

22.2

134

XCH05

NOMESCO Finland

Eye pressure longterm registration

3.7

22.1

192

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

22.1

416

2513

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

22.0

1891

15470

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

21.9

164

720

SPAT1262

SPAT

Handing over of treatment supplies

1.5

21.9

919

6665

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

21.9

606

4031

H30.2

ICD-10 Finland

Posterior cyclitis

+∞

21.9

A12AA04

ATC

calcium carbonate; oral

3.1

21.8

308

C09CA06

ATC

candesartan; oral

1.4

21.8

1143

8638

B01AB05

ATC

enoxaparin; parenteral

1.4

21.7

1667

13398

A10BH05

ATC

linagliptin; oral

1.8

21.7

338

1934

C07AB02

ATC

metoprolol; systemic

1.4

21.6

1240

9510

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

21.6

254

1329

K78

ICPC

Atrial fibrillation/flutter

1.6

21.3

554

3632

H54.1

ICD-10 Finland

Severe visual impairment, binocular

20.8

21.2

NHQ40

NOMESCO Finland

Amputation of toe

2.8

21.1

109

401

C10AA07

ATC

rosuvastatin; oral

1.3

21.1

1642

13213

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

21.1

1136

8616

H16.0

ICD-10 Finland

Corneal ulcer

2.1

21.0

210

1036

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.1

20.9

274

CKD50

NOMESCO Finland

Endodiathermy of retina

+∞

20.8

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

20.7

610

4112

PAW37

NOMESCO Finland

Biopsy of temporal artery

3.6

20.7

187

CS2P4

NOMESCO Finland

Optic nerve head imaging

3.8

20.7

164

CD2S4

NOMESCO Finland

Photography of eye

4.6

20.5

105

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

20.5

341

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

20.5

1877

15458

B03XA02

ATC

darbepoetin alfa; parenteral

2.4

20.1

136

572

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

20.0

3002

26425

S01EB01

ATC

pilocarpine; ophthalmic

3.6

19.8

178

N18.0

ICD-10 Finland

End-stage renal disease

3.3

19.7

232

C03DA01

ATC

spironolactone; oral

1.5

19.7

750

5329

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3.2

19.7

253

SPAT1301

SPAT

No procedures

1.3

19.5

1608

13016

207

Kela drug reimbursment

Chronic arrhythmias

1.4

19.4

1066

8099

B01AF02

ATC

apixaban; oral

1.4

19.3

866

6347

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

19.3

511

3361

K85

ICPC

Elevated blood pressure

1.4

19.2

938

6979

Z2221

NOMESCO Finland

Medical doctor

1.4

19.2

1226

9542

B05DA

ATC

Isotonic solutions

4.5

19.1

103

CHD50

NOMESCO Finland

Shunt operation on anterior chamber

7.2

19.1

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

19.1

1563

12635

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

18.8

658

4595

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

18.8

1514

12201

H33.4

ICD-10 Finland

Traction detachment of retina

+∞

18.8

H40.8

ICD-10 Finland

Other glaucoma

4.9

18.7

B05DB

ATC

Hypertonic solutions

4.7

18.6

1LA04, ,

NOMESCO Finland

100.4

18.6

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.6

18.5

103

395

R04.0

ICD-10 Finland

Epistaxis

1.6

18.4

455

2946

SPAT1325

SPAT

Vaccination

1.3

18.3

1777

14691

F99

ICPC

Eye/adnexa disease other

3.8

18.3

146

I50.0

ICD-10 Finland

Congestive heart failure

1.5

18.2

550

3723

A28

ICPC

Limited function/disability NOS

1.4

18.2

1205

9421

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

18.2

2058

17369

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

18.1

1769

14632

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.5

17.9

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

17.9

651

4581

AN1

Coronary angiography

1.5

17.8

694

4949

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.8

17.8

273

1555

CHC05

NOMESCO Finland

Iridotomy

2.6

17.8

101

391

H46

ICD-10 Finland

Optic neuritis

5.0

17.8

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

17.8

2263

19376

H30.9

ICD-10 Finland

Chorioretinal inflammation, unspecified

+∞

17.7

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

17.7

114

469

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

17.7

612

4263

R03AC02

ATC

salbutamol; inhalant

1.3

17.6

2412

20833

J01AA02

ATC

doxycycline; systemic

1.3

17.6

3782

34611

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.6

17.6

103

405

196

Kela drug reimbursment

Paricalcitol and cinacalcet

5.4

17.6

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

17.4

622

4359

H40

ICD-10 Finland

Glaucoma

2.9

17.4

294

H44.0

ICD-10 Finland

Purulent endophthalmitis

24.1

17.3

CA1ME

NOMESCO Finland

Ultrasound oculometry

4.1

17.3

116

K02.1

ICD-10 Finland

Caries of dentine

1.3

17.2

2326

20036

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.0

17.1

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

17.1

1759

14625

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.8

17.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

17.0

868

6499

Z49.2

ICD-10 Finland

Other dialysis

4.1

16.8

114

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

16.7

1997

16918

CL2L4

NOMESCO Finland

Wide-field fundus photography for diabetic retinopathy screening

+∞

16.7

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

16.6

1720

14298

V03AE02

ATC

sevelamer; oral

4.9

16.6

H53

ICD-10 Finland

Visual disturbances

4.1

16.6

111

H34

ICD-10 Finland

Retinal vascular occlusions

170.5

16.5

CKD95

NOMESCO Finland

Extended combined vitectomy and lens procedure through pars plana

27.6

16.5

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.6

16.5

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.1

16.4

R02

ICPC

Shortness of breath/dyspnoea

1.4

16.4

708

5143

H40.19

ICD-10 Finland

Other primary glaucoma with open ventricular angle

6.1

16.4

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

3.4

16.3

168

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.5

16.2

510

3480

C08CA05

ATC

nifedipine; systemic

1.6

16.2

349

2182

J01FF01

ATC

clindamycin; systemic

1.3

16.1

1202

9541

CHB10

NOMESCO Finland

Puncture of anterior chamber of eye with irrigation

4.8

16.1

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.1

16.1

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

16.1

1304

10477

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.0

16.1

185

962

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

16.0

812

6065

J01MA02

ATC

ciprofloxacin; systemic

1.3

16.0

1998

16992

F28

ICPC

Limited function/disability (F)

3.7

15.8

133

CKC30

NOMESCO Finland

Cryopexy of detached retina

+∞

15.6

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

2.2

15.5

132

613

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.6

15.5

324

CKC60

NOMESCO Finland

Local buckling of sclera using implant

160.5

15.5

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

15.4

1035

8083

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

15.4

1400

11420

SPAT1254

SPAT

Administration of medicine

1.4

15.3

801

6015

CHD15

NOMESCO Finland

Trabeculectomy and iridectomy

3.6

15.3

141

ZXE00

NOMESCO Finland

One hour or less

1.3

15.2

1732

14535

WX199

NOMESCO Finland

Other local analgesia

1.9

15.2

194

1045

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

15.0

648

4705

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.7

14.9

279

1682

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.2

14.9

122

559

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

14.8

302

1864

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.1

14.8

194

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.2

14.8

116

522

SPAT1009

SPAT

Measurement of intraocular pressure

2.6

14.7

327

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.0

14.7

154

775

N19

ICD-10 Finland

Unspecified kidney failure

1.8

14.6

242

1410

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

14.6

1685

14151

I65.3

ICD-10 Finland

Occlusion and stenosis of multiple and bilateral precerebral arteries

5.6

14.6

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.0

14.6

104

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

5.1

14.6

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

14.5

385

2532

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

14.5

668

4904

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

14.4

251

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

14.3

1820

15462

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

14.2

142

702

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

4.0

14.2

H05BX01

ATC

cinacalcet; oral

3.8

14.2

115

SPAT1310

SPAT

Counselling related to known health issue

1.3

14.2

1425

11750

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

3.2

14.2

168

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

14.1

379

2498

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.2

14.1

113

513

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

14.1

496

3462

I20.09

ICD-10 Finland

Unstable angina

1.6

14.1

345

2228

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

14.0

667

4921

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

14.0

307

1931

C10AA04

ATC

fluvastatin; oral

1.5

13.9

514

3620

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

13.9

437

2980

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

13.9

1014

8002

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

13.9

351

2282

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

13.8

860

6630

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.7

13.8

267

1625

C09AA02

ATC

enalapril; systemic

1.3

13.8

1097

8764

CKA10

NOMESCO Finland

Biopsy of vitreous body

20.1

13.8

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

13.8

1279

10435

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.0

13.7

208

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.4

13.7

645

4749

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

13.6

867

6703

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

13.6

1146

9229

H3602, E113,

ICD-10 Finland

+∞

13.5

H3601, E116,

ICD-10 Finland

+∞

13.5

J01MA12

ATC

levofloxacin; systemic

1.3

13.5

949

7445

N03AX16

ATC

[U] pregabalin

1.3

13.5

1045

8313

ZXD05

NOMESCO Finland

Urgent procedure

1.3

13.4

1373

11332

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

13.4

195

1094

SPAT1097

SPAT

Recording of ECG

1.4

13.4

756

5735

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

13.4

342

2228

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

3.9

13.4

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

6.1

13.4

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

13.4

352

2310

V03AE01

ATC

polystyrene sulfonate; oral

2.5

13.3

320

PD5AD

NOMESCO Finland

CT of aorta

2.0

13.3

139

700

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

2.2

13.2

113

527

SFA10

NOMESCO Finland

One-surface restoration

1.2

13.2

2198

19203

R55

ICD-10 Finland

Syncope and collapse

1.4

13.1

611

4490

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

2.3

13.1

439

N02AX02

ATC

tramadol; systemic, rectal

1.2

13.0

2084

18120

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

13.0

640

4749

R50.9

ICD-10 Finland

Fever, unspecified

1.4

13.0

697

5246

V03AE03

ATC

lanthanum carbonate; oral

5.2

12.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

12.8

1529

12848

C09DA06

ATC

candesartan and diuretics; oral

1.5

12.8

363

2423

A10BK03

ATC

empagliflozin; oral

1.4

12.7

503

3588

F01

ICPC

Eye pain

2.1

12.7

114

542

CFW99

NOMESCO Finland

Other operation on conjunctiva

5.8

12.7

OAB50, ,

SPAT

1.5

12.7

376

2532

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

12.7

265

1645

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

12.7

717

5439

PE1AT

NOMESCO Finland

Femoral artery PTA

2.4

12.6

346

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.4

12.6

513

3678

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

12.6

466

3282

H43.3

ICD-10 Finland

Other vitreous opacities

2.7

12.6

235

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

12.6

826

6409

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

12.6

830

6446

CK2P4

NOMESCO Finland

Optic nerve head light layer imaging (OCT)

3.6

12.5

116

H36.8*I70.8

ICD-10 Finland

Atherosclerotic retinopathy

+∞

12.5

WZC30

NOMESCO Finland

Teaching

1.4

12.4

751

5756

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.2

12.4

151

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.7

12.4

248

1523

H18.1

ICD-10 Finland

Bullous keratopathy

5.6

12.4

UJF32

NOMESCO Finland

Coloscopy

1.3

12.4

1318

10916

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2.3

12.4

418

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

12.3

1277

10547

WX213

NOMESCO Finland

Lower leg blockade

3.1

12.2

168

H44.5

ICD-10 Finland

Degenerated conditions of globe

10.5

12.2

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

9.6

12.2

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

12.2

284

1812

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

5.1

12.2

U02

ICPC

Urinary frequency/urgency

1.4

12.1

670

5062

M54.5

ICD-10 Finland

Low back pain

1.3

12.1

1498

12626

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

12.1

614

4576

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.3

12.0

379

Z01.2

ICD-10 Finland

Dental examination

1.2

12.0

1765

15169

EBA00

NOMESCO Finland

Extraction of tooth

1.3

12.0

1505

12706

CKD99

NOMESCO Finland

Other intraoclular operations on vitreous body and retina

46.8

11.9

R51.80

ICD-10 Finland

Headache

1.4

11.8

549

4029

M48.0

ICD-10 Finland

Spinal stenosis

1.4

11.8

677

5144

J01DA01

ATC

[U] cefalexin

1.2

11.8

2812

25399

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.0

11.8

119

592

FXZ00

NOMESCO Finland

Off-pump cardiac operation

3.1

11.8

151

R60.0

ICD-10 Finland

Localized oedema

1.4

11.8

678

5157

SPAT1260

SPAT

Consultation of another employee

1.3

11.7

804

6275

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

11.7

858

6763

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.6

11.7

245

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

11.7

253

1587

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

11.6

710

5448

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.7

11.6

225

1371

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

11.6

312

2059

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.2

11.6

450

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

2.7

11.5

218

M04AA01

ATC

allopurinol; systemic

1.3

11.5

779

6069

CKC70

NOMESCO Finland

Circular buckling of sclera

+∞

11.5

1BA01, ,

NOMESCO Finland

120.3

11.4

H35.29

ICD-10 Finland

Other proliferative retinopathy

120.3

11.4

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.8

11.4

153

839

A04

ICPC

Weakness/tiredness general

1.3

11.4

769

5987

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

11.3

174

994

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

11.3

810

6362

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

11.1

2153

19001

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.4

11.0

294

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.7

11.0

206

1244

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

3.5

11.0

102

E0000UV, ,

ATC

1.2

11.0

1821

15816

H33.2

ICD-10 Finland

Serous retinal detachment

43.4

10.9

Z2446

NOMESCO Finland

Social worker

1.6

10.9

249

1582

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

10.9

767

6006

R4110

NOMESCO Finland

Physiotherapy

1.3

10.9

1292

10816

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

5.4

10.9

WX872

NOMESCO Finland

Intensive care

1.6

10.9

258

1655

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

10.8

474

3444

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.0

10.8

109

543

A11

ICPC

Chest pain NOS

1.4

10.8

421

2996

WZC00, ,

SPAT

1.4

10.7

599

4530

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

10.7

331

2250

H47.3

ICD-10 Finland

Other disorders of optic disc

5.6

10.7

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

10.6

2590

23345

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.3

10.6

830

6592

G04CA02

ATC

tamsulosin; oral

1.2

10.6

1404

11891

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

10.6

470

3422

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.5

10.6

290

1922

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.1

10.5

135

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.4

10.5

110

TK810

NOMESCO Finland

Hemofiltration

3.3

10.5

115

H02.4

ICD-10 Finland

Ptosis of eyelid

1.8

10.5

141

775

QDB10, ,

SPAT

1.9

10.5

135

732

H30.8

ICD-10 Finland

Other chorioretinal inflammations

+∞

10.4

I70.8

ICD-10 Finland

Atherosclerosis of other arteries

3.3

10.4

111

S21

ICPC

Skin texture symptom/complaint

1.3

10.4

705

5492

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

10.4

321

2184

H16.9

ICD-10 Finland

Keratitis, unspecified

2.4

10.3

297

N06AX11

ATC

mirtazapine; oral

1.2

10.3

1499

12818

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

10.3

556

4182

H43.2

ICD-10 Finland

Crystalline deposits in vitreous body

5.1

10.3

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

3.8

10.3

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

10.2

1589

13683

I25.2

ICD-10 Finland

Old myocardial infarction

1.4

10.2

415

2978

G04CB01

ATC

finasteride; oral

1.3

10.2

687

5347

XF404

NOMESCO Finland

Ambulatory ECG

1.4

10.1

436

3157

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

10.1

1741

15142

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.3

10.1

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

10.1

891

7189

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

10.0

248

1606

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

4.3

10.0

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.0

10.0

A02BC05

ATC

esomeprazole; systemic

1.2

10.0

1831

16022

SPAT1153

SPAT

Removal of sutures

1.2

10.0

1511

12967

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

10.0

331

2283

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

10.0

356

2492

S01FA01

ATC

atropine; ophthalmic

4.0

9.9

R05

ICPC

Cough

1.3

9.9

1027

8448

XKD00

NOMESCO Finland

Uroflowmetry

1.3

9.9

895

7239

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

9.8

727

5727

A10BK01

ATC

dapagliflozin; oral

1.4

9.8

366

2582

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

9.8

746

5901

K03.66

ICD-10 Finland

Tooth plaque

1.5

9.8

321

2210

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.5

9.8

302

2054

WX290

NOMESCO Finland

Other blockage of nerve

1.2

9.7

1572

13575

SPAT1216

SPAT

Assessment of functional ability

1.3

9.7

869

7018

H01.0

ICD-10 Finland

Blepharitis

1.6

9.7

223

1420

E87.5

ICD-10 Finland

Hyperkalaemia

1.9

9.7

110

572

A02BC03

ATC

lansoprazole; oral

1.2

9.7

1341

11396

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

9.7

1048

8665

M10.9

ICD-10 Finland

Gout, unspecified

1.4

9.7

389

2785

Z00.0

ICD-10 Finland

General medical examination

1.3

9.6

861

6959

A29

ICPC

General symptom/complaint other

1.3

9.6

671

5248

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

9.5

245

1601

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

9.5

629

4876

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

9.5

372

2648

SPAT1312

SPAT

General health counselling

1.2

9.5

1317

11187

321

Kela drug reimbursment

Paricalcitol and cinacalcet

3.1

9.5

123

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.8

9.4

133

743

CH2S4

NOMESCO Finland

Photography of iris

30.1

9.4

H3602, E103,

ICD-10 Finland

+∞

9.4

3623C

ICD-9 Finland

Other retinal disorders, Retinal vascular occlusion[OCCLUSIO VENAE CENTRALIS RETINAE]

+∞

9.4

H3603, E107,

ICD-10 Finland

+∞

9.4

37703

ICD-8 Finland

Other diseases of retina and optic nerve, Thrombosis venae centralis retinae

+∞

9.4

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.5

9.4

270

1810

C09DA01

ATC

losartan and diuretics; oral

1.4

9.3

524

3965

CH2X4

NOMESCO Finland

Optical coherence tomography (OCT) of iris and iridocorneal angle

21.7

9.3

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.3

9.3

615

4768

A10BB12

ATC

glimepiride; oral

1.4

9.3

380

2727

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

4.5

9.3

C07AG02

ATC

carvedilol; oral

1.5

9.2

321

2235

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

9.2

208

1319

M31.6

ICD-10 Finland

Other giant cell arteritis

3.8

9.2

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.8

9.2

163

SFA30

NOMESCO Finland

Three-surface restoration

1.2

9.2

1667

14544

J45.9

ICD-10 Finland

Asthma, unspecified

1.3

9.2

822

6639

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.8

9.2

145

838

C08CA10

ATC

nilvadipine; oral

1.9

9.1

105

549

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

9.1

1029

8542

B01AC07

ATC

dipyridamole; systemic

1.5

9.1

280

1903

-1, ,

NOMESCO Finland

1.2

9.1

1166

9818

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.4

9.1

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.4

9.1

351

2495

ZX199

NOMESCO Finland

Other rote

11.5

9.0

H44.1

ICD-10 Finland

Other endophthalmitis

11.5

9.0

I20.01

ICD-10 Finland

Unstable angina

1.7

9.0

171

1038

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.3

9.0

561

4311

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.6

9.0

216

1390

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

9.0

681

5379

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

9.0

138

791

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

2.0

8.9

484

J01CF05

ATC

flucloxacillin; systemic

1.5

8.9

278

1895

G47.3

ICD-10 Finland

Sleep apnoea

1.3

8.9

897

7347

CHD35

NOMESCO Finland

Laser goniopuncture

3.2

8.9

107

J01FA06

ATC

roxithromycin; oral

1.2

8.9

1710

14996

XF402

NOMESCO Finland

ECG with work load test

1.3

8.8

512

3894

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.8

8.8

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

3.6

8.8

D07AC01

ATC

betamethasone; topical

1.2

8.8

1602

13972

XCX10

NOMESCO Finland

Other photography of eye

8.6

8.8

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

8.8

1551

13487

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.8

8.8

136

782

I72.4

ICD-10 Finland

Aneurysm and dissection of artery of lower extremity

3.2

8.7

103

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

3.3

8.7

C09CA03

ATC

valsartan; oral

1.4

8.7

459

3439

RS221, ,

NOMESCO Finland

2.4

8.7

245

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

8.7

1432

12364

S01BA01

ATC

dexamethasone; ophthalmic

1.7

8.7

143

836

WX892

NOMESCO Finland

Monitored bed care

1.4

8.7

361

2599

ZX120

NOMESCO Finland

Intravenous

1.4

8.7

414

3053

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

3.1

8.6

114

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.4

8.6

391

2859

K77

ICPC

Heart failure

1.7

8.6

151

899

SPAT1053

SPAT

Memory test

1.3

8.6

890

7314

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

2.6

8.6

187

S29

ICPC

Skin symptom/complaint other

1.3

8.5

921

7603

H02AB04

ATC

methylprednisolone; systemic

1.3

8.5

609

4773

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

1.9

8.5

103

549

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.4

8.5

318

2247

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

8.5

215

1402

SFA20

NOMESCO Finland

Two-surface restoration

1.2

8.5

2201

19805

M10.0

ICD-10 Finland

Idiopathic gout

1.6

8.5

191

1212

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

8.5

260

1767

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

8.5

195

1244

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.2

8.4

299

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

90.2

8.4

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.7

8.4

160

975

TCA20

NOMESCO Finland

Peribulbar therapeutic injection into orbit

7.8

8.3

H3601, E106,

ICD-10 Finland

+∞

8.3

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

+∞

8.3

H3601, E118,

ICD-10 Finland

+∞

8.3

TK820

NOMESCO Finland

Peritoneal dialysis

3.7

8.3

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.6

8.3

192

1226

E66.8

ICD-10 Finland

Other obesity

1.7

8.3

149

893

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

8.3

491

3747

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

2.1

8.3

328

I65.0

ICD-10 Finland

Occlusion and stenosis of vertebral artery

4.1

8.2

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

8.2

2807

25827

R06AE07

ATC

cetirizine; oral

1.2

8.2

1705

15029

ZXD20

NOMESCO Finland

Day surgery

1.3

8.2

493

3768

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

8.2

198

1277

J20

ICD-10 Finland

Acute bronchitis

1.4

8.2

392

2891

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.2

8.2

290

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

2.8

8.2

134

D06

ICPC

Abdominal pain localized other

1.4

8.2

336

2415

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

8.2

457

3456

L03

ICPC

Low back symptom/complaint

1.2

8.2

1159

9849

3651B

ICD-9 Finland

Glaucoma, Open-angle glaucoma[GLAUCOMA CAPSULARE (AVOKULMA)]

4.5

8.1

RS222, ,

NOMESCO Finland

2.4

8.1

235

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

8.1

199

1291

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

8.1

294

2068

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

1.9

8.0

496

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

8.0

298

2104

A10BH01

ATC

sitagliptin; oral

1.3

8.0

462

3512

H02.3

ICD-10 Finland

Blepharochalasis

1.4

8.0

291

2047

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

7.2

7.9

P20

ICPC

Memory disturbance

1.2

7.9

898

7447

SPAT1229

SPAT

Assessment of need for aid

1.4

7.9

400

2977

UKC02

NOMESCO Finland

Cystoscopy

1.2

7.9

881

7296

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

3.9

7.9

R01AD09

ATC

mometasone; nasal

1.2

7.8

1661

14658

P01AB01

ATC

metronidazole; oral, rectal

1.2

7.8

1587

13949

S01FA04

ATC

cyclopentolate; ophthalmic

2.4

7.8

202

J45

ICD-10 Finland

Asthma

1.4

7.8

376

2779

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.0

7.8

390

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

15.0

7.7

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

7.7

359

2638

H03AA01

ATC

levothyroxine sodium; systemic

1.2

7.7

967

8111

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

7.6

1294

11181

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

7.6

984

8273

KMAK, ,

NOMESCO Finland

1.2

7.6

1885

16850

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.4

7.6

391

2919

E66.00

ICD-10 Finland

Metabolic syndrome

1.5

7.6

203

1341

-50

ICPC

Medication/prescr/renewal

1.6

7.6

190

1237

PD4AD

NOMESCO Finland

CT of lower extremity arteries

2.4

7.6

217

UDC00

NOMESCO Finland

Ear microscopy

1.4

7.6

310

2228

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.5

7.6

187

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.5

7.5

245

1686

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

6.1

7.5

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

7.5

280

1978

D68.8

ICD-10 Finland

Other specified coagulation defects

2.6

7.5

158

J01FA09

ATC

clarithromycin; systemic

1.2

7.5

1137

9720

H02

ICPC

Hearing complaint

1.3

7.5

774

6354

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.0

7.4

383

H54.7

ICD-10 Finland

Unspecified visual loss

3.1

7.4

CD1AE

NOMESCO Finland

Other special ultrasound examination of the eye

80.2

7.4

R52.9

ICD-10 Finland

Pain, unspecified

1.3

7.4

419

3175

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

2.5

7.4

177

C03AA03

ATC

hydrochlorothiazide; oral

1.3

7.3

477

3688

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.3

1150

9858

J01FA10

ATC

azithromycin; systemic

1.2

7.3

2099

18973

S01BA07

ATC

fluorometholone; ophthalmic

2.1

7.3

291

R06

ICPC

Nose bleed/epistaxis

1.7

7.3

128

763

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

7.3

496

3858

A10AD05

ATC

insulin aspart; parenteral

1.9

7.3

448

SPAT1255

SPAT

Intravenous administration of medicine

1.4

7.3

315

2285

H35.20

ICD-10 Finland

Proliferative vitreoretinopathy

+∞

7.3

H3603, E106,

ICD-10 Finland

+∞

7.3

H3600, E116,

ICD-10 Finland

+∞

7.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

7.3

317

2303

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.6

7.3

148

918

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

7.3

1080

9209

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.8

7.2

121

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

7.2

1696

15074

H26.3

ICD-10 Finland

Drug-induced cataract

3.3

7.2

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.2

1633

14472

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

7.1

995

8428

L04AX01

ATC

azathioprine; systemic

1.6

7.1

145

899

F94

ICPC

Blindness

30.0

7.1

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.4

7.1

266

1880

H40.6

ICD-10 Finland

Glaucoma secondary to drugs

20.0

7.1

Z01.7

ICD-10 Finland

Laboratory examination

1.3

7.1

661

5357

TQW11

NOMESCO Finland

Vacuum treatment of wound

1.8

7.1

503

Angiography of the heart and coronary arteries

1.4

7.1

365

2727

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

7.1

415

3162

K90

ICPC

Stroke/cerebrovascular accident

1.6

7.1

167

1074

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.5

7.1

163

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

1.6

7.1

173

1122

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

3.6

7.0

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

7.0

621

5002

PD1AE

NOMESCO Finland

Ultrasound examination of abdominal aortta

2.4

7.0

194

280

Kela drug reimbursment

Clopidogrel

1.9

7.0

462

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

7.0

307

2234

A03

ICPC

Fever

1.3

7.0

524

4133

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

7.0

729

5987

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.3

6.9

220

C10AA03

ATC

pravastatin; oral

1.4

6.9

374

2815

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.6

6.9

152

962

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

6.9

164

1057

DAX08

NOMESCO Finland

Fitting of hearing aid

1.4

6.9

314

2300

PEN23

NOMESCO Finland

Plastic repair of femoral artery

2.2

6.9

240

K65.0

ICD-10 Finland

Acute peritonitis

2.2

6.9

266

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

6.9

400

3046

SPAT1104

SPAT

Monitoring of emergency patient

1.4

6.9

293

2123

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.4

6.8

258

1828

3025

Kela drug reimbursment

Calcium carbonate

2.7

6.8

125

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

6.8

1235

10720

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

1.9

6.8

423

XPX08

NOMESCO Finland

Intraoperative flow measurement

2.2

6.8

234

H02AB07

ATC

prednisone; oral

1.3

6.8

599

4822

H33

ICD-10 Finland

Retinal detachments and breaks

9.3

6.8

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

6.8

909

7670

NH3J4

NOMESCO Finland

Thermal imaging of the feet and legs

40.1

6.8

A01

ICPC

Pain general/multiple sites

1.3

6.7

440

3405

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.6

6.7

159

1023

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

2.5

6.7

161

K87

ICPC

Hypertension complicated

1.6

6.7

142

890

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

2.3

6.7

223

Z3226

NOMESCO Finland

Physiotherapist

1.2

6.7

781

6490

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.3

6.7

580

4658

R31

ICD-10 Finland

Unspecified haematuria

1.3

6.7

553

4415

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

7.2

6.7

C09CA07

ATC

telmisartan; oral

1.4

6.7

325

2406

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

1.7

6.7

112

661

A10AB06

ATC

insulin glulisine; parenteral

2.6

6.7

144

OAB42, ,

SPAT

1.3

6.7

478

3747

SPAT1281

SPAT

Other administrative function

1.4

6.7

311

2287

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

6.7

444

3446

I50

ICD-10 Finland

Heart failure

1.5

6.7

192

1291

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.6

6.7

133

822

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.3

6.6

363

2738

R07.3

ICD-10 Finland

Other chest pain

1.3

6.6

447

3475

AN4

Balloon angioplasty and drug eluding stent

1.5

6.6

168

1099

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.4

6.6

246

1739

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

4.0

6.6

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

6.6

158

1020

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

7.8

6.6

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

6.6

400

3064

H35

ICD-10 Finland

Other retinal disorders

12.2

6.6

L75

ICPC

Fracture: femur

1.9

6.6

415

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

6.6

805

6727

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

6.6

979

8345

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.4

6.6

H54.0

ICD-10 Finland

Blindness, binocular

8.7

6.5

K25

ICPC

Fear of hypertension

1.5

6.5

179

1192

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.8

6.5

100

576

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

6.5

172

1138

H65.2

ICD-10 Finland

Chronic serous otitis media

2.2

6.5

240

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

2.3

6.4

208

RS220, ,

NOMESCO Finland

2.3

6.4

208

S01.0

ICD-10 Finland

Open wound of scalp

1.3

6.4

381

2909

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.5

6.4

153

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

6.4

1034

8878

H84

ICPC

Presbyacusis

1.4

6.4

234

1650

A02BC01

ATC

omeprazole; systemic

1.2

6.4

1277

11176

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.8

6.4

557

A10AD01

ATC

insulin (human); parenteral

2.1

6.4

294

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

14.3

6.4

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

6.4

753

6265

L04AD01

ATC

ciclosporin; systemic

2.1

6.4

274

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.3

6.4

452

3538

S01BA04

ATC

prednisolone; ophthalmic

1.8

6.4

528

R35

ICD-10 Finland

Polyuria

1.4

6.4

333

2495

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.7

6.4

119

724

A10AD04

ATC

insulin lispro; parenteral

3.7

6.4

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.7

6.3

117

709

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

6.3

288

2110

M54.4

ICD-10 Finland

Lumbago with sciatica

1.3

6.3

650

5328

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

1.8

6.3

515

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

6.3

425

3305

PD3AT

NOMESCO Finland

Pelvic artery PTA

2.7

6.3

125

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

6.3

809

6793

R03BB04

ATC

tiotropium bromide; inhalant

1.3

6.3

511

4073

H27.0

ICD-10 Finland

Aphakia

3.8

6.2

H3601, E1100,

ICD-10 Finland

+∞

6.2

H31.3

ICD-10 Finland

Choroidal haemorrhage and rupture

+∞

6.2

H3601, E119,

ICD-10 Finland

+∞

6.2

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

+∞

6.2

H35.1

ICD-10 Finland

Retinopathy of prematurity

+∞

6.2

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

+∞

6.2

TCK00

NOMESCO Finland

Photosensitisation of choroid and retina

+∞

6.2

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

6.2

454

3568

H26.02

ICD-10 Finland

Presenil cataract

1.8

6.2

481

R33

ICD-10 Finland

Retention of urine

1.3

6.2

443

3472

3AC01, ,

NOMESCO Finland

2.4

6.2

168

A99

ICPC

Disease/condition unspecnature/site

1.3

6.2

449

3527

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.4

6.2

270

1966

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.6

6.1

118

723

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.5

6.1

175

1175

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

6.1

224

1579

ZPB22

NOMESCO Finland

Autograft of vein

2.7

6.1

121

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

6.1

503

4013

A10BB01

ATC

glibenclamide; oral

1.4

6.1

213

1488

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

2.0

6.1

299

G44.2

ICD-10 Finland

Tension-type headache

1.3

6.1

442

3470

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.5

6.1

154

1008

F03

ICPC

Eye discharge

1.4

6.1

227

1607

K30

ICD-10 Finland

Functional dyspepsia

1.3

6.1

421

3286

J05AB11

ATC

valaciclovir; oral

1.3

6.1

566

4586

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.6

6.1

119

733

S22.3

ICD-10 Finland

Fracture of rib

1.4

6.1

312

2332

XA800

NOMESCO Finland

Neuropsychological investigation

1.6

6.1

130

819

L03.9

ICD-10 Finland

Cellulitis, unspecified

1.8

6.1

492

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.0

6.1

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

6.1

222

1567

WX402

NOMESCO Finland

General anaesthesia

1.2

6.0

829

7004

U05

ICPC

Urination problems other

1.4

6.0

269

1965

H27.1

ICD-10 Finland

Dislocation of lens

3.1

6.0

TK830

NOMESCO Finland

Ultrafiltration

10.0

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3032080) INR in Blood by Coagulation assay

3344

25284

1.86

99.20

24.2

19.3

1.39

1.36

inr

2.18

2894

21325

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2366

16178

1.83

96.83

2.5

2.2

200.26

220.74

u/l

0.54

2256

15185

(3013826) Glucose [Moles/volume] in Serum or Plasma

3696

29166

1.86

91.75

7.0

5.2

6.98

6.80

mmol/l

5.77

3572

27800

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1355

8281

1.85

75.97

2.3

2.0

30.18

29.95

0.55

1333

8039

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2479

18187

1.67

71.70

3.9

3.4

2324.11

1755.51

ng/l

5.00

2190

15994

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3978

33359

1.74

66.40

5.4

4.6

15.68

14.35

mm/h

5.09

3698

30797

(3019550) Sodium [Moles/volume] in Serum or Plasma

4901

44102

2.27

63.82

32.7

24.2

139.34

139.58

mmol/l

7.65

4820

43171

(3023103) Potassium [Moles/volume] in Serum or Plasma

4904

44148

2.28

63.66

33.1

24.4

4.01

4.00

mmol/l

0.68

4816

43157

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4597

40429

1.95

63.48

8.7

7.1

41.49

40.03

mmol/mol

21.28

4251

37017

(3020682) Albumin/Creatinine [Ratio] in Urine

2330

17270

1.62

61.50

4.7

4.0

12.43

8.40

mg/mmol

3.72

1556

10776

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4759

42467

2.06

61.38

26.5

19.7

26.17

27.85

mg/l

2.96

4222

36177

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3284

26505

1.62

60.23

10.4

7.3

1.21

mmol/l

2.22

2844

22722

(3013115) Eosinophils [#/volume] in Blood

3033

24078

1.60

59.08

7.3

6.2

0.20

e9/l

0.81

2614

20585

(3037467) Urinalysis macro (dipstick) panel - Urine

3804

31980

1.65

57.74

6.1

5.1

1.51

2.03

—

(3001604) Monocytes [#/volume] in Blood

2947

23312

1.59

57.66

7.1

6.0

0.63

0.62

e9/l

0.98

2515

19589

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2611

20086

1.58

57.59

5.5

4.4

125.82

81.18

ng/l

0.50

2155

15794

(3006315) Basophils [#/volume] in Blood

2957

23421

1.58

57.45

7.1

6.0

0.04

e9/l

0.21

2528

19701

(3009508) Creatinine [Moles/volume] in Urine

2299

17177

1.59

57.41

4.0

3.3

6.73

7.22

mmol/l

7.49

1921

14227

(3012516) Albumin [Mass/volume] in Urine

2264

16857

1.59

57.36

4.0

3.4

66.59

48.82

mg/l

2.64

1556

10856

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4599

40783

1.89

57.17

6.1

5.4

4.18

4.44

mmol/l

57.73

4251

37236

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4565

40442

1.86

56.15

6.1

5.3

1.39

1.44

mmol/l

17.58

4179

36637

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4927

44822

2.20

55.89

34.8

26.5

91.31

83.35

umol/l

20.20

4858

44114

(4195642) Thrombophilia screening test

171

456

3.84

55.86

1.1

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

2986

23796

1.57

55.75

7.2

6.1

1.78

1.85

e9/l

1.32

2591

20481

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4676

41768

1.92

55.69

7.1

6.2

2.32

2.54

mmol/l

57.42

4318

38003

(3031040) Bacteria [#/volume] in Urine by Automated count

3760

31635

1.63

55.66

6.3

5.4

2446.33

1704.59

e6/l

0.29

537

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4414

38774

1.78

55.03

5.2

4.5

1.28

1.27

mmol/l

0.46

3983

34666

(3018010) Neutrophils/Leukocytes in Blood

2745

21500

1.57

54.98

7.2

6.3

59.76

58.67

4.96

2607

20393

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

173

471

3.76

54.86

1.1

1.2

118.02

113.02

1.12

160

421

(3019069) Monocytes/Leukocytes in Blood

2767

21722

1.56

54.78

7.3

6.4

9.19

9.15

0.21

2582

20180

(3006504) Eosinophils/Leukocytes in Blood

2758

21671

1.56

54.12

7.2

6.3

2.88

2.82

0.63

2570

20142

(3022096) Basophils/Leukocytes in Blood

2756

21661

1.56

53.95

7.3

6.4

0.66

0.65

0.46

2565

20125

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4454

39292

1.78

53.88

6.0

5.4

2.10

2.04

mu/l

1.21

4065

35595

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1954

14218

1.59

53.55

2.8

2.4

3.04

2.95

mg/l

0.86

1705

12155

(3000963) Hemoglobin [Mass/volume] in Blood

4940

45127

2.18

53.11

39.3

29.9

130.78

132.35

g/l

9.73

4874

44479

(3010813) Leukocytes [#/volume] in Blood

4940

45129

2.18

53.07

39.0

29.7

7.06

6.93

e9/l

2.80

4804

43793

(3035941) MCH [Entitic mass]

4939

45120

2.18

53.00

38.8

29.6

30.43

30.44

0.20

4867

44442

(3024731) MCV [Entitic mean volume] in Red Blood Cells

4939

45120

2.18

53.00

38.9

29.6

91.85

91.80

0.31

4868

44442

(3002030) Lymphocytes/Leukocytes in Blood

2784

21983

1.55

52.98

7.3

6.4

24.74

25.96

6.75

2625

20679

(3026361) Erythrocytes [#/volume] in Blood

4939

45122

2.18

52.96

39.0

29.7

4.34

4.38

e12/l

5.84

4802

43793

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

4939

45123

2.18

52.94

39.8

30.3

39.05

39.55

7.20

4868

44428

(3007461) Platelets [#/volume] in Blood

4938

45117

2.17

52.81

39.0

29.7

238.05

241.43

e9/l

3.15

4831

43970

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

178

512

3.56

52.04

1.3

1.2

3.20

4.91

u/ml

1.38

231

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2911

23271

1.55

51.98

2.5

2.3

92.84

93.81

pmol/l

0.53

1628

12340

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

183

537

3.49

51.89

1.3

1.2

3.11

3.96

u/ml

0.29

184

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4142

35947

1.67

51.67

10.0

8.5

81.33

82.13

u/l

0.47

3915

33976

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4850

44108

2.03

51.13

15.9

13.2

24.31

25.09

u/l

1.07

4696

42486

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4596

41231

1.80

48.42

6.4

5.7

6.20

6.06

mmol/l

9.84

4147

37012

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2559

20085

1.52

48.30

4.0

3.1

142.36

154.83

ug/l

1.75

2340

18338

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

169

494

3.50

48.21

1.1

—

(3036489) Thrombin time

369

1638

2.35

48.17

2.1

1.9

21.73

21.25

0.30

309

1502

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2939

23800

1.52

47.54

9.4

6.6

1.20

1.21

mmol/l

2.46

2700

21817

(3013650) Neutrophils [#/volume] in Blood by Automated count

3205

26452

1.52

47.25

10.2

9.4

4.46

4.32

e9/l

2.38

2793

22646

(3023368) Bacteria identified in Blood by Culture

2114

16000

1.53

46.84

5.2

4.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1293

8817

1.61

44.97

3.7

2.6

2.23

2.25

g/l

0.83

1202

8076

(3024561) Albumin [Mass/volume] in Serum or Plasma

2880

23391

1.50

44.72

6.4

5.0

34.57

34.67

g/l

0.44

2665

21758

(3022948) Iron [Moles/volume] in Serum or Plasma

1356

9400

1.59

43.85

3.7

2.6

11.15

11.98

umol/l

4.90

1265

8680

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3142

26062

1.50

43.38

7.0

6.7

12.00

12.44

umol/l

1.13

2983

24842

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1209

8199

1.61

42.69

3.8

2.7

20.47

21.41

1.88

1137

7571

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

295

1254

2.43

42.38

2.2

2.1

96.02

89.35

5.85

286

1217

(3021960) Folate [Moles/volume] in Serum or Plasma

2078

15996

1.49

40.76

1.9

1.8

19.56

20.00

nmol/l

0.59

1756

13445

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4485

40464

1.66

40.00

26.1

19.8

69.59

73.09

ml/min/173m2

24.01

4236

37815

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1383

9823

1.55

39.52

2.1

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2031

15650

1.48

39.19

2.9

2.7

59.61

66.15

u/l

0.64

1882

14447

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3761

32682

1.50

38.91

4.6

4.3

15.26

15.08

pmol/l

3.88

3376

29413

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

163

5.03

37.99

1.1

1.2

1.08

ratio

0.13

127

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1058

7157

1.60

37.07

9.7

5.5

1.07

1.04

mmol/l

4.21

990

6602

(3026008) Bacteria identified in Urine by Culture

2151

16894

1.46

36.98

4.0

3.7

—

(3035350) Ketones [Presence] in Urine by Test strip

2972

24825

1.44

36.48

5.3

4.4

7.14

3.50

estimate

0.48

716

5438

(3009261) Glucose [Presence] in Urine by Test strip

2980

24994

1.43

35.18

5.3

4.4

0.08

0.27

estimate

0.42

649

5082

(3027945) Reticulocytes/Erythrocytes in Blood

1042

7102

1.58

35.13

2.7

2.4

1.84

1.78

1.04

936

6238

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2683

22109

1.43

34.76

3.3

2.9

—

estimate

—

(3020779) Urea [Moles/volume] in Serum or Plasma

809

5199

1.65

34.70

11.5

6.4

12.26

11.14

mmol/l

3.98

775

4936

(3002582) Erythrocytes [#/volume] in Urine

2166

17181

1.44

34.60

4.4

3.7

97.58

79.00

e6/l

0.27

1754

13304

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3112

26365

1.43

34.36

3.7

3.3

53.19

55.74

u/l

0.78

2852

24162

(3026493) Urate [Moles/volume] in Serum or Plasma

1689

12813

1.46

34.09

3.4

3.0

366.39

357.39

umol/l

2.68

1470

11019

(3018095) Leukocytes [#/volume] in Urine

2337

18829

1.43

34.08

5.3

4.3

86.56

120.83

e6/l

1.97

1788

13672

(3033658) Prothrombin time (PT) actual/Normal

1633

12320

1.47

33.86

5.4

4.3

83.27

84.34

0.87

1604

12060

(3021601) Nitrite [Presence] in Urine by Test strip

2921

24515

1.42

33.69

5.3

4.3

0.00

estimate

1.34

689

5248

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

126

388

3.30

33.18

1.1

1.2

92.40

94.20

0.29

120

360

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2553

20984

1.41

32.80

2.7

2.4

80.14

79.51

nmol/l

0.53

2265

18491

(3003396) Base excess in Arterial blood by calculation

995

6809

1.57

32.70

7.6

7.0

0.69

1.03

mmol/l

1.49

820

5545

(3044640) Blood type and Crossmatch panel - Blood

2029

16052

1.42

32.18

3.2

2.6

—

(3002032) Base excess in Venous blood by calculation

861

5733

1.60

31.74

5.8

3.6

1.75

1.86

mmol/l

0.39

748

4967

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

978

6717

1.56

31.51

4.3

4.4

246.46

247.72

u/l

0.11

922

6313

(3012544) pH of Venous blood

886

5959

1.58

31.25

5.8

3.6

7.38

0.45

564

3490

(3019977) pH of Arterial blood

992

6857

1.55

31.00

7.7

7.1

7.42

0.06

538

3787

(3000991) Gas panel - Venous blood

754

4926

1.62

29.94

11.0

8.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

844

5672

1.58

29.75

8.3

7.7

118.33

119.90

g/l

1.46

830

5537

(3027801) Oxygen [Partial pressure] in Arterial blood

986

6870

1.53

29.56

7.8

7.0

11.86

11.99

kpa

0.34

946

6587

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

986

6872

1.53

29.51

7.8

7.0

5.01

5.09

kpa

1.88

942

6594

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

761

5000

1.61

29.49

2.8

2.4

6.61

7.00

ug/l

0.18

656

4296

(3021447) Carbon dioxide [Partial pressure] in Venous blood

868

5890

1.57

29.29

5.8

3.6

5.83

5.82

kpa

0.08

847

5738

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1594

12235

1.43

29.22

3.0

2.6

—

(3016502) Oxygen saturation in Arterial blood

898

6155

1.55

28.95

8.0

7.2

95.25

95.31

0.10

875

5930

(3044889) 12 lead EKG panel

3589

31635

1.41

28.73

5.4

4.7

6.11

1217.51

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

251

1177

2.19

28.61

2.6

2.4

186.83

208.60

3.46

239

1116

(3000850) Epithelial cells [#/volume] in Urine

1572

12083

1.43

28.43

3.4

2.8

4.87

5.00

e6/l

0.15

1441

11006

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1332

9935

1.45

28.35

1.9

1.7

1.42

1.55

mg/l

0.56

1069

7855

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1397

10524

1.44

28.16

5.4

4.3

415.49

468.18

ng/l

0.19

1208

9112

(3021589) Normoblasts [#/volume] in Blood

2408

19925

1.38

28.07

15.5

12.7

0.00

e9/l

0.46

1975

16115

(4268621) Lupus anticoagulant assay

114

367

3.15

27.96

2.4

2.3

—

(3007853) Bacteria identified in Skin by Aerobe culture

840

5718

1.56

27.83

2.1

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

492

2929

1.75

27.71

1.8

1.7

1.56

1.58

g/l

0.25

423

2499

(3015736) pH of Urine

2393

19845

1.37

27.20

4.6

3.8

6.33

6.28

1.21

1297

10730

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1039

7448

1.49

26.90

2.0

1.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

380

2118

1.85

26.65

1.3

1.5

4.16

15.54

iu/ml

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1381

10478

1.43

26.49

1.9

1.8

1149.54

1160.46

nmol/l

0.16

1042

7878

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

105

5.18

26.40

1.0

1.1

99.64

90.13

1.25

(3015377) Calcium [Moles/volume] in Serum or Plasma

2168

17792

1.37

25.90

3.8

3.5

2.35

mmol/l

1.61

1941

15936

(3020630) Protein [Mass/volume] in Serum or Plasma

748

5046

1.56

25.63

2.8

2.7

66.24

65.89

g/l

0.64

682

4543

(3030467) Casts [#/volume] in Urine by Automated count

1851

14847

1.38

25.38

4.3

3.6

0.43

0.49

e6/l

0.81

1453

11137

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1196

8919

1.44

24.99

3.9

3.1

0.81

mmol/l

0.04

1140

8318

(3042936) Bacteria identified in Isolate by Culture

1011

7303

1.47

24.98

2.4

2.0

—

(3013512) EKG study

2171

17892

1.36

24.95

4.8

4.1

1.00

0.71

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1817

14564

1.37

24.90

3.5

3.3

32.66

36.88

u/l

1.41

1700

13600

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

967

6928

1.48

24.90

2.0

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

811

5606

1.53

24.82

2.7

2.5

70.11

67.64

e9/l

1.08

612

4128

(3029937) Albumin [Presence] in Urine by Test strip

1764

14154

1.37

23.73

5.3

4.5

0.00

estimate

0.28

610

4708

(3037522) Nuclear Ab [Titer] in Serum

793

5509

1.52

23.62

1.4

1.3

722.50

480.45

titre

2.11

176

1241

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2190

18228

1.34

22.95

5.4

4.5

0.39

0.47

estimate

0.09

573

4313

(3018418) pH of Serum or Plasma

1960

16066

1.35

22.69

6.2

4.2

7.40

1.21

1460

11688

(3014111) Lactate [Moles/volume] in Serum or Plasma

744

5147

1.52

22.52

9.2

7.0

1.37

1.38

mmol/l

0.02

729

5034

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

353

2026

1.79

22.46

2.1

2.2

562.18

711.04

ug/l

0.36

336

1929

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2484

21103

1.33

22.44

2.6

2.5

—

(36304419) Bacteria [Presence] in Urine

1730

13935

1.36

22.39

4.2

3.5

0.33

180.66

estimate

0.61

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

510

3248

1.63

22.14

6.8

3.6

24.07

24.23

mmol/l

0.56

504

3205

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

321

1804

1.83

21.88

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

713

4935

1.51

21.47

4.6

3.0

4.58

4.40

kpa

0.94

693

4798

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

176

3.73

20.94

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

539

3540

1.58

20.53

9.5

7.7

24.43

24.90

mmol/l

1.99

532

3516

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

530

3469

1.59

20.49

10.1

8.9

24.03

24.29

mmol/l

0.89

512

3374

(3026782) Osmolality of Urine

1329

10418

1.37

20.03

3.9

3.2

505.18

534.26

mosm/kgh2o

6.43

1189

9131

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

114

4.33

19.40

1.1

4.33

5.53

u/ml

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

303

2.94

19.33

2.3

27.06

35.03

iu/ml

0.44

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

615

4223

1.52

19.11

6.1

3.6

119.20

95.28

ng/l

5.18

533

3561

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

309

1794

1.77

18.89

1.9

1.8

39.38

38.11

u/l

0.52

261

1532

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

551

3707

1.54

18.82

4.5

3.8

5.10

5.15

kpa

0.60

525

3505

(3030981) Hyaline casts [#/volume] in Urine by Automated count

648

4529

1.49

18.46

3.1

2.6

0.50

e6/l

0.01

634

4380

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.10

18.32

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

3704

33771

1.31

17.93

32.9

24.5

14.05

13.92

6.25

3666

33277

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

601

4168

1.50

17.75

1.9

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

101

4.38

17.74

1.1

1.0

—

(3009343) pH of Capillary blood

531

3591

1.53

17.67

4.5

3.8

7.42

0.05

451

2970

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

699

5003

1.46

17.59

3.4

3.1

258.25

237.39

ng/l

0.54

657

4603

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1391

11174

1.33

17.41

1.9

1.8

46852937.76

26500763.74

pmol/l

0.46

1112

9098

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

251

1404

1.83

17.39

1.7

1.4

4.15

19.66

iu/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

252

1417

1.82

17.17

1.5

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

540

3697

1.51

16.95

4.4

3.1

123.80

127.42

g/l

3.23

527

3577

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

471

3149

1.54

16.49

4.3

3.6

1.67

2.07

mmol/l

1.40

361

2311

(3036481) Cortisol [Moles/volume] in Serum or Plasma

594

4169

1.48

16.49

2.2

2.3

388.49

385.90

nmol/l

0.09

538

3829

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

4.34

16.36

1.0

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

237

1328

1.82

16.34

2.6

2.3

3.61

3.63

g/l

0.04

229

1262

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.03

16.17

14.2

12.9

6.13

5.05

mmol/l

0.45

(3027273) Bicarbonate [Moles/volume] in Venous blood

419

2748

1.57

15.97

4.2

3.3

25.15

25.16

mmol/l

0.02

404

2662

(3041096) Erythrocytes [Presence] in Urine by Automated

1515

12440

1.30

15.92

4.8

3.9

0.07

0.37

estimate

1.41

552

4062

(3008152) Bicarbonate [Moles/volume] in Arterial blood

531

3685

1.49

15.56

5.9

6.3

24.44

24.58

mmol/l

0.34

511

3529

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1171

9321

1.33

15.31

3.9

3.3

1.10

1.50

e6/l

0.63

691

5123

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

486

3327

1.51

15.22

9.7

9.2

15.68

15.80

0.47

473

3213

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

437

2929

1.54

15.11

1.6

1.5

—

(40758558) Short blood count panel - Blood

1679

14052

1.28

15.06

7.8

6.5

—

(40768446) Kidney Pathology biopsy report

134

3.61

14.88

2.0

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

220

1243

1.80

14.78

1.5

1.16

1.18

g/l

0.37

213

1172

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

215

1211

1.81

14.60

1.5

0.24

g/l

0.14

208

1144

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

530

3725

1.47

14.55

1.9

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

332

2116

1.61

14.29

3.6

2.8

0.34

0.35

iu/ml

0.10

197

1170

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1081

8583

1.32

14.26

4.1

3.4

2.06

2.32

e6/l

0.52

603

4376

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

3628

33425

1.26

13.76

34.6

25.9

330.71

331.15

g/l

2.06

3601

33165

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2122

18410

1.25

13.74

6.1

3.22

3.78

ug/l

0.49

1903

16461

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

169

914

1.88

13.10

7.7

4.6

637.03

3261.43

iu/ml

0.72

134

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

591

4323

1.41

13.03

2.0

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

474

3331

1.46

12.99

2.9

2.8

10.62

10.50

g/l

0.21

442

3041

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1325

10930

1.28

12.95

3.3

3.2

2.46

2.47

mmol/l

0.18

1185

9752

(3011397) Hemoglobin [Presence] in Urine by Test strip

1413

11759

1.27

12.85

5.0

4.1

0.28

0.50

0.28

162

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

442

3078

1.48

12.69

4.2

2.6

0.63

0.01

442

3066

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

142

733

1.96

12.67

1.7

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

322

2.48

12.63

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1134

9204

1.29

12.53

5.6

4.9

—

(3019150) Specific gravity of Urine by Refractometry

1335

11070

1.27

12.43

5.6

4.7

1.02

1.15

kg/l

0.51

942

7540

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

444

3108

1.47

12.41

4.2

2.6

1.18

1.17

0.08

444

3093

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

373

2522

1.51

12.37

2.5

2.4

3.86

3.69

g/l

1.08

339

2262

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

373

2526

1.51

12.28

2.5

2.4

4.16

4.19

g/l

0.29

340

2268

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

373

2529

1.51

12.21

2.5

2.4

7.43

7.51

g/l

0.38

340

2264

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

351

2356

1.52

12.05

2.5

2.4

2.98

2.93

g/l

0.36

317

2096

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

126

638

2.00

11.90

1.8

1.3

155.41

162.37

au/ml

0.32

191

(3017143) Hepatitis C virus Ab [Presence] in Serum

510

3692

1.42

11.90

2.0

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

210

1248

1.71

11.90

1.6

1.5

0.68

12.76

iu/ml

1.16

263

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

303

1980

1.56

11.75

3.1

3.3

3.08

5.25

ratio

0.50

186

1175

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

326

2174

1.53

11.54

2.4

10.55

10.12

g/l

0.97

288

1886

(3023420) DNA double strand Ab [Units/volume] in Serum

261

1654

1.61

11.54

1.8

1.6

12.14

6.61

iu/ml

0.76

399

(3022313) Gas panel - Capillary blood

365

2493

1.50

11.54

4.6

4.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

308

2030

1.55

11.50

1.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

328

2193

1.53

11.47

3.3

3.4

43.94

53.94

mg/l

0.63

275

1861

(46235355) HIV 1 and 2 tests - Meaningful Use set

629

4748

1.37

11.44

2.0

1.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

328

2197

1.53

11.38

3.3

3.4

54.10

83.75

mg/l

0.63

274

1868

(3003181) Sodium [Moles/volume] in Urine

190

1113

1.73

11.35

1.5

1.4

62.15

61.66

mmol/l

0.06

155

893

(3025159) Blasts/Leukocytes in Blood

577

4302

1.38

11.32

5.0

4.3

0.67

0.17

0.75

163

1220

(3007164) IgA [Mass/volume] in Serum or Plasma

947

7600

1.30

11.27

1.6

1.5

2.58

2.64

g/l

0.41

551

4333

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

279

1807

1.57

11.26

2.5

2.4

0.04

0.03

g/l

0.13

256

1606

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.54

11.16

1.7

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

1470

12459

1.25

11.14

4.0

3.3

0.16

0.07

0.76

446

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

388

2702

1.47

11.14

2.4

2.5

24.30

22.73

au/ml

0.10

205

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

324

2176

1.52

11.10

2.7

2.4

0.75

0.95

g/l

0.53

274

1840

(3020876) Protein [Mass/time] in 24 hour Urine

132

698

1.91

11.03

2.3

2.4

1.23

1.16

g/24h

0.16

400

(3018405) Lactate [Moles/volume] in Arterial blood

292

1923

1.55

10.95

3.4

3.7

1.39

1.40

mmol/l

0.04

287

1889

(3017732) Neutrophils [#/volume] in Blood

717

5573

1.33

10.72

3.4

4.84

4.88

e9/l

0.05

599

4677

(3010375) cycloSPORINE [Mass/volume] in Blood

144

3.07

10.71

37.5

27.4

111.29

113.95

ug/l

0.10

117

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

322

2179

1.51

10.65

2.1

2.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

424

3036

1.43

10.51

5.3

4.1

46.30

46.41

0.03

415

2990

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

699

5438

1.33

10.37

4.0

3.8

—

(3002179) Metamyelocytes/Leukocytes in Blood

568

4284

1.36

10.35

4.4

4.1

0.76

0.70

0.28

180

1407

(3019832) Treponema pallidum Ab [Presence] in Serum

246

1580

1.58

10.31

1.4

1.5

—

(3045414) Leukocytes [Presence] in Urine

622

4761

1.35

10.30

2.3

2.2

0.01

estimate

0.12

135

869

(3025941) Bacteria identified in Stool by Culture

314

2130

1.50

10.28

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

376

2646

1.45

10.23

2.2

2.0

1.51

1.37

g/l

0.40

353

2385

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

225

1418

1.61

10.21

4.3

2.5

2.05

1.75

mg/l

4.09

208

1249

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

172

1015

1.72

10.05

1.5

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

352

2455

1.46

10.04

1.3

73.28

58.96

au/ml

0.35

171

(3021901) Oxygen saturation in Capillary blood

201

1238

1.65

10.01

3.3

3.0

89.57

88.88

0.92

196

1206

(3048929) Epstein Barr virus Ab [Presence] in Serum

153

876

1.77

9.95

1.4

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

187

1133

1.67

9.92

2.5

2.2

152.49

102.12

ug/min

0.73

105

632

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

113

589

1.94

9.89

1.4

1.5

—

(3000494) Fungus identified in Specimen by Culture

697

5457

1.32

9.87

1.6

1.4

—

(3021440) Promyelocytes/Leukocytes in Blood

567

4322

1.35

9.64

4.9

4.2

0.12

0.11

0.07

158

1306

(3019225) pH of Specimen

661

5154

1.32

9.62

5.4

4.5

7.36

0.05

462

3665

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

261

1730

1.53

9.54

2.6

2.4

0.00

g/l

0.36

233

1498

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

514

3867

1.36

9.51

3.3

2.7

52.07

60.47

ml/min/173m2

6.41

251

1687

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

283

1910

1.51

9.51

1.4

1.3

—

(40768804) Tissue Pathology biopsy report

2042

18133

1.20

9.41

2.4

2.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

893

7272

1.27

9.33

1.3

49.77

38.50

iu/ml

0.89

271

2165

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

244

1608

1.54

9.17

2.7

2.4

0.00

g/l

-0.00

233

1492

(3021879) Hepatitis B virus core Ab [Presence] in Serum

348

2465

1.44

9.16

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

3.38

9.15

5.9

4.5

—

(3017181) Myelocytes/Leukocytes in Blood

587

4534

1.33

9.12

4.9

4.2

0.95

0.96

0.03

180

1510

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

129

723

1.80

9.05

3.4

2.3

1019.63

2010.62

u/ml

—

(21494890) Protein electrophoresis panel - 24 hour Urine

115

622

1.87

9.04

1.9

2.1

—

(3024928) Oxygen saturation in Venous blood

217

1398

1.58

9.02

4.7

2.6

63.98

59.37

2.26

212

1352

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1030

8563

1.25

9.00

1.3

1.92

1.80

u/ml

0.09

238

2111

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1952

17327

1.20

8.89

2.1

1.9

1.32

1.31

mmol/l

0.20

1616

14201

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

700

5572

1.29

8.73

3.2

2.6

7.87

9.78

umol/l

1.51

601

4892

(3045424) Erythrocytes [Presence] in Urine

335

2378

1.44

8.72

2.3

2.2

0.01

0.40

estimate

0.52

660

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

139

806

1.74

8.70

2.5

1.3

0.90

0.85

nmol/l

0.30

117

674

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

114

623

1.85

8.69

1.4

1.2

267.68

285.69

u/ml

0.29

378

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

131

747

1.77

8.69

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

181

1128

1.63

8.65

2.1

1.9

12.51

12.40

mg/l

0.06

163

1027

(3034426) Prothrombin time (PT)

109

3.13

8.63

1.3

29.74

28.57

0.25

109

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

277

1911

1.47

8.39

4.6

4.1

24.52

24.95

mmol/l

1.37

249

1705

(3023199) Leukocytes [#/volume] in Pleural fluid

138

814

1.71

8.16

1.4

1.5

1076.86

3096.73

e6/l

1.14

566

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

732

5910

1.28

8.14

5.8

5.2

33.69

33.32

0.40

481

3738

(3052851) Hemolysis interference index of Serum or Plasma

222

1473

1.53

8.12

4.0

3.5

3.38

1.91

index

0.92

117

761

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

158

970

1.65

8.04

1.2

141.67

324.14

titre

1.41

(3020891) Body temperature

369

2706

1.39

8.00

5.1

4.4

36.91

°c

0.03

362

2672

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

462

3516

1.34

7.93

1.6

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

264

2.25

7.81

1.2

27.96

26.23

u/l

0.11

222

(3024932) HLA-DR beta [Type]

3.31

7.78

1.0

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

351

2568

1.39

7.72

1.9

1.76

2.06

ug/l

0.27

304

2238

(3037756) Immunofixation for Serum or Plasma

203

1341

1.53

7.60

1.5

1.6

—

(3024471) HLA-A [Type]

3.23

7.51

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

737

6013

1.26

7.49

10.5

8.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

227

1547

1.49

7.35

1.2

0.67

1.17

u/ml

0.47

131

(3037121) Protein [Mass/volume] in Urine

259

1817

1.45

7.23

3.6

2.9

1147.04

490.35

mg/l

0.57

136

770

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

216

1470

1.49

7.05

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

126

757

1.68

7.02

6.8

6.1

11.23

12.62

mg/l

2.57

114

698

(40768797) Stomach Pathology biopsy report

789

6536

1.24

6.99

1.2

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

277

2.14

6.98

1.2

103.25

95.66

u/l

0.21

237

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

289

2082

1.41

6.98

3.0

2.7

—

(3049717) Cytology report of Urine Cyto stain

323

2374

1.38

6.94

2.6

2.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

815

6787

1.24

6.88

1.3

15.83

13.83

u/ml

0.25

277

2395

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

199

1343

1.50

6.78

1.6

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

588

4731

1.27

6.70

2.1

2.2

144.56

159.70

ug/g

0.47

455

3731

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

129

792

1.64

6.64

1.3

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

121

731

1.67

6.62

1.4

1.5

58577.75

56815.16

e6/l

0.02

409

(44806071) Cardiolipin IgM antibody measurement

4.16

6.54

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

398

3057

1.33

6.44

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

149

958

1.57

6.36

1.5

29.79

31.18

g/l

0.75

132

855

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

626

5112

1.25

6.29

2.3

2.1

0.20

g/l

0.19

581

4731

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

357

2712

1.34

6.24

4.6

1.58

1.57

0.06

343

2565

(3003129) Base excess in Capillary blood by calculation

108

644

1.69

6.23

2.7

2.4

0.37

mmol/l

0.00

102

620

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

123

760

1.63

6.20

2.1

2.3

32.64

32.71

0.07

123

753

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

174

1165

1.51

6.19

1.7

1.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

568

4601

1.26

6.11

2.8

2.5

36.63

40.26

u/l

0.69

463

3882

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

200

1382

1.46

6.10

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1656

14860

1.17

6.05

5.0

22.37

22.30

0.07

889

7977

(3004775) Volume in Urine collected for unspecified duration

379

1.89

5.95

2.5

2.1

635.48

647.32

0.11

237

(4027681) Cerebrospinal fluid IgG ratio and IgG index

166

2.36

5.87

1.3

1.2

0.57

0.55

ratio

0.14

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

107

648

1.66

5.85

1.3

301.31

341.57

u/l

0.34

102

608

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

390

1.86

5.78

1.6

1.4

77.50

62.41

titre

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

166

1118

1.50

5.77

1.3

1.2

27.62

3.08

u/ml

0.65

109

(3023183) Ammonium ion [Moles/volume] in Plasma

165

1112

1.50

5.72

2.2

2.5

29.95

33.75

umol/l

1.53

153

982

(43055442) Apixaban [Mass/volume] in Serum or Plasma

120

2.59

5.70

1.4

1.7

109.48

120.67

ug/l

0.23

106

(40761535) Cells panel - Urine sediment

506

4080

1.27

5.67

4.3

3.6

—

2.40

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

172

1172

1.48

5.66

1.3

1.2

51.65

35.66

u/ml

0.24

(3007930) Methemoglobin/Hemoglobin.total in Blood

327

2491

1.33

5.63

4.7

4.8

0.88

0.86

0.27

312

2352

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

474

1.76

5.62

1.6

1.7

31.00

25.74

u/ml

0.26

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

403

1.82

5.54

1.6

1.4

388.57

328.57

titre

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

433

1.79

5.50

1.3

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

165

1122

1.49

5.49

1.3

2.44

5.74

u/ml

1.59

170

(3038515) Glucose [Moles/volume] in Venous blood

188

1312

1.45

5.48

3.8

3.5

8.11

7.61

mmol/l

0.91

182

1276

(3000093) Morphology [Interpretation] in Blood Narrative

538

1.70

5.47

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

2.26

5.47

1.7

2.4

9.35

10.13

kpa

1.37

178

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

178

2.26

5.47

1.7

2.4

4.88

4.87

kpa

0.01

178

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

237

2.08

5.46

1.1

361.84

289.23

mg/l

0.71

207

(3000034) Microalbumin [Mass/volume] in Urine

427

1.79

5.45

3.8

2.9

76.90

25.09

mg/l

1.35

312

(3044242) Glucose [Moles/volume] in Arterial blood

364

1.85

5.36

1.6

1.8

8.37

8.04

mmol/l

0.34

364

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

313

2388

1.33

5.35

3.3

4.23

4.39

pmol/l

2.36

279

2084

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

144

958

1.52

5.34

1.7

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

299

2267

1.34

5.33

1.3

200.35

251.99

u/ml

0.72

281

2074

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

490

1.73

5.31

1.2

58.06

66.71

u/l

0.84

435

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

181

2.22

5.27

3.2

2.5

0.61

0.62

mmol/l

0.18

181

(3051611) Lipemic interference index of Serum or Plasma

522

1.70

5.24

3.3

3.5

11.59

12.17

index

0.29

272

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

255

2.01

5.21

1.2

1.1

51.90

41.47

mg/l

0.70

216

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

997

1.50

5.18

1.3

1.4

—

(3016750) Collection duration of Urine

256

2.00

5.16

2.5

1.9

486.92

497.83

min

0.30

183

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

168

1162

1.46

5.16

1.3

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

164

2.26

5.13

1.2

1.3

153.81

165.58

mmol/24h

0.37

164

(3014765) Yersinia sp identified in Stool by Organism specific culture

169

1175

1.45

5.06

1.3

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

144

970

1.50

5.05

1.3

1.2

4.93

6.54

u/ml

0.15

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

211

1531

1.39

4.99

1.8

1.7

—

(3008037) Lactate [Moles/volume] in Venous blood

211

1531

1.39

4.99

3.6

3.4

1.67

1.63

mmol/l

0.19

206

1484

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

110

702

1.58

4.94

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

164

1140

1.45

4.92

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

540

1.66

4.90

3.7

3.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

169

1183

1.44

4.89

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

145

988

1.48

4.83

1.3

46.18

41.55

u/l

0.17

124

860

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

291

1.90

4.81

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

291

1.90

4.81

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

4.84

4.80

1.2

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

144

2.30

4.76

1.2

1.1

—

(1616796) Gas panel - Central venous blood

176

1251

1.42

4.70

4.3

4.0

—

(3047181) Lactate [Moles/volume] in Blood

224

1659

1.37

4.69

5.1

5.5

1.31

1.36

mmol/l

0.39

202

1481

(3012441) Differential panel - Pleural fluid

112

727

1.55

4.69

1.5

—

(3017704) Immunofixation for Urine

323

1.84

4.66

1.7

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

232

1.99

4.63

1.8

4.4

82.22

69.82

mg/l

0.36

158

(40761536) Microorganisms panel - Urine sediment

453

3703

1.24

4.53

5.2

4.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

608

1.59

4.49

1.4

1.3

289.86

288.48

pmol/l

0.01

502

(3022621) pH of Urine by Test strip

465

3820

1.24

4.45

3.2

3.1

6.11

6.07

0.35

320

2730

(3022145) Colonoscopy Study observation

625

5294

1.20

4.42

1.4

—

(3011985) Renin [Units/volume] in Plasma

101

650

1.56

4.42

1.4

56.67

63.76

mu/l

0.13

575

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

356

2843

1.27

4.37

2.5

—

(3038026) Centromere Ab [Units/volume] in Serum

338

1.78

4.35

1.2

67.50

83.61

u/ml

—

(21494755) Public health laboratory ask at order entry panel

103

1552

0.66

4.33

1.3

1.4

—

(3045788) Cell count panel - Pleural fluid

102

662

1.55

4.31

1.4

1.5

—

(3002256) Pathology report gross observation

749

6466

1.18

4.28

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

211

1574

1.35

4.26

3.6

3.3

0.82

0.81

nmol/l

0.12

171

1254

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

120

809

1.49

4.26

1.3

1.2

57.35

50.12

u/ml

0.13

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

167

1199

1.41

4.25

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

167

1199

1.41

4.25

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

247

1.91

4.24

1.7

1.50

2.17

u/field

0.72

162

(3000475) Leukocytes [#/volume] in Synovial fluid

183

1339

1.38

4.17

1.6

12544.69

15147.85

e6/l

0.69

137

933

(3004616) Nuclear Ab [Presence] in Serum

542

1.60

4.13

1.3

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

466

1.64

4.08

2.1

2.0

1.52

1.39

u/field

0.12

235

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

498

1.62

4.05

1.3

10.62

12.84

u/l

0.95

450

(3003694) ABO and Rh group [Type] in Blood

1298

11729

1.14

4.03

1.4

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.20

4.00

1.1

1.3

—

(3022689) Creatine [Moles/volume] in Urine

131

2.22

3.91

1.3

1.4

6.81

7.25

mmol/l

0.25

131

(3036782) Glucose [Moles/volume] in Pleural fluid

641

1.52

3.82

1.4

6.74

6.25

mmol/l

0.90

593

(1761482) Bacteria [#/volume] in Urine by Culture

197

1482

1.34

3.80

5.2

4.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.07

3.80

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

516

4357

1.20

3.79

5.4

4.1

1.23

mmol/l

0.27

445

3769

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

8.76

3.77

2.9

5.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

424

1.64

3.71

1.7

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

424

1.64

3.71

1.7

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

424

1.64

3.71

1.7

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

348

1.70

3.70

2.1

1.8

104.39

110.40

ng/l

0.23

348

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

296

1.76

3.69

2.4

2.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

173

1284

1.36

3.66

1.9

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

5.63

3.65

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

183

1.97

3.62

1.1

0.99

1.20

u/l

2.29

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

569

1.54

3.61

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.40

3.55

1.1

—

(1761868) Lipid panel - Serum or Plasma

1402

12825

1.13

3.53

4.0

3.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

220

1.87

3.53

1.1

—

(3010421) pH of Blood

224

1739

1.30

3.49

4.1

3.9

7.40

7.41

1.56

217

1718

(40768806) Pleura Pathology biopsy report

104

715

1.46

3.42

1.5

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

184

1394

1.33

3.42

2.8

2.3

126.53

125.76

g/l

0.17

153

1078

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

396

1.62

3.38

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

320

1.69

3.36

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

572

1.51

3.34

1.1

48.85

386.24

iu/ml

0.52

(3035285) Chloride [Moles/volume] in Venous blood

107

744

1.45

3.33

2.4

105.53

105.68

mmol/l

0.12

107

736

(3041354) Potassium [Moles/volume] in Venous blood

107

744

1.45

3.33

2.4

4.16

4.11

mmol/l

0.53

107

736

(3044009) aPTT.lupus sensitive (LA screen)

4.35

3.30

1.1

1.2

—

(3017569) Oxygen content in Arterial blood

370

1.63

3.23

2.1

2.0

15.09

16.00

1.75

370

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

526

4517

1.18

3.23

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

105

734

1.44

3.19

2.4

1.20

mmol/l

0.12

105

726

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.37

3.18

5.0

5.5

391.29

351.18

umol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

150

1117

1.35

3.16

1.2

65.00

112.82

titre

—

103

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

229

1.80

3.15

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

272

2195

1.25

3.14

1.2

85.10

123.83

u/ml

1.55

102

744

(3040151) Glucose [Moles/volume] in Capillary blood

100

696

1.45

3.12

82.6

5.9

7.40

7.15

mmol/l

0.39

574

(3001964) Herpes simplex virus Ag [Presence] in Specimen

111

2.17

3.12

1.4

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

558

1.50

3.09

1.1

1.3

0.20

nmol/l

0.09

455

(3000330) Specific gravity of Urine by Test strip

337

2790

1.22

3.07

4.6

3.9

1.02

ratio

2.20

309

2541

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

7.51

3.05

1.0

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.51

3.05

1.5

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

139

2.02

3.05

1.2

—

(3044927) Protein electrophoresis panel - Urine

618

1.46

3.02

1.3

1.2

—

(3014891) Appearance of Pleural fluid

2.26

3.02

1.6

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

247

1.75

3.02

1.7

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

247

1.75

3.02

1.7

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

247

1.75

3.02

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

247

1.75

3.02

1.7

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

103

726

1.43

3.02

1.6

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

354

1.62

3.01

1.4

1.2

96.46

106.34

pmol/l

0.66

354

(4024509) Urine culture

299

2455

1.23

2.96

2.2

2.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.83

2.91

1.4

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

149

1124

1.33

2.91

1.2

840.00

1085.71

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

336

1.61

2.85

1.1

1.2

285.00

137.22

titre

0.51

(3016650) Hepatitis A virus Ab [Presence] in Serum

610

1.45

2.84

1.1

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

143

1.96

2.84

1.3

11.79

23.47

3.04

119

(3000570) Elastase.pancreatic [Mass/mass] in Stool

191

1497

1.29

2.84

1.4

245.97

268.17

ug/g

0.80

115

921

(3047189) Immunofixation for 24 hour Urine

298

1.65

2.82

1.5

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

224

1.75

2.77

1.2

1.3

1.20

1.26

nmol/l

0.13

168

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

202

1.79

2.76

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

133

998

1.34

2.71

1.3

1.4

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

126

940

1.35

2.68

1.3

1.2

3.88

3.83

mmol/l

0.23

116

875

(3036525) Urea [Moles/time] in 24 hour Urine

3.75

2.67

3.1

4.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

160

1239

1.30

2.63

1.7

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

141

1.92

2.59

2.2

2.0

28.67

211.22

ug/l

0.47

131

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.67

2.59

5.3

6.4

—

(3019174) dRVVT (LA screen)

3.60

2.57

1.1

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

156

1.86

2.56

2.8

2.1

157.07

177.31

0.51

147

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

140

1069

1.32

2.56

1.4

1.3

549.85

577.27

mg/l

0.32

130

1011

(3043410) Blood group antigens tested for on Red Blood Cells

142

1.91

2.55

1.5

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

689

6151

1.14

2.54

3.9

4.2

15.36

22.84

ug/l

0.74

574

5141

(3012501) Base excess in Blood by calculation

147

1131

1.31

2.54

4.5

4.6

2.55

2.73

mmol/l

0.34

772

(3013290) Carbon dioxide [Partial pressure] in Blood

147

1131

1.31

2.54

4.5

4.6

4.98

5.00

kpa

0.14

138

1108

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

633

1.41

2.54

1.2

1.3

0.59

0.67

nmol/l

2.38

605

(3004716) Salmonella sp identified in Stool by Organism specific culture

193

1539

1.26

2.53

1.4

1.2

—

(3000012) Reticulocyte production index

124

932

1.34

2.53

2.1

0.95

0.88

0.80

639

(37208534) Antinuclear antibody arbitrary concentration in serum

115

2.00

2.50

1.1

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

356

1.55

2.50

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

172

1.81

2.49

2.0

25328.60

54104.44

u/ml

—

(3028707) Methadone [Presence] in Urine by Screen method

209

1.73

2.49

2.6

2.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

263

1.64

2.47

1.5

2.0

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

102

2.06

2.46

1.0

1.2

0.34

0.30

g/l

1.10

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

113

843

1.35

2.43

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

147

1139

1.30

2.43

4.5

4.6

8.46

8.35

kpa

0.36

138

1115

(3008898) HLA-B27 [Presence]

119

895

1.34

2.43

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

249

1.65

2.42

2.2

2.1

597.06

510.76

e6/l

0.42

202

(3028271) Lactate [Moles/volume] in Capillary blood

118

887

1.34

2.42

2.1

1.9

1.71

1.70

mmol/l

0.05

112

865

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

490

1.45

2.40

1.4

1.5

—

(3017354) Segmented neutrophils/Leukocytes in Blood

625

1.40

2.37

3.2

3.7

60.03

58.20

0.29

511

(3004451) EKG impression Narrative

337

1.55

2.37

1.5

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.64

2.36

4.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

132

1.90

2.35

1.3

25.41

33.78

0.66

(40759836) Histone Ab [Presence] in Serum by Immunoblot

306

1.57

2.35

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

184

1474

1.26

2.35

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

618

1.40

2.34

1.5

62.66

62.56

0.01

394

(3014271) Vancomycin [Susceptibility]

346

1.54

2.34

2.5

3.0

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

252

1.63

2.32

3.8

2.6

43.09

37.82

0.91

149

(3011412) CD3 cells [#/volume] in Blood

396

1.50

2.30

2.2

2.0

1098.31

1087.27

e6/l

0.04

350

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

253

1.63

2.29

2.3

2.2

206.64

227.81

e6/l

0.35

220

(3021788) Differential panel - Synovial fluid

126

966

1.31

2.27

1.5

—

1.00

—

(3016038) Potassium [Moles/volume] in Urine

414

1.48

2.26

1.3

1.1

35.63

35.14

mmol/l

0.06

346

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

119

906

1.32

2.26

1.4

1.3

28.10

33.39

e6/l

0.09

670

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

530

1.42

2.25

1.2

1.3

—

nmol/l

—

(3023419) Bacteria identified in Sputum by Culture

717

1.36

2.24

3.3

2.5

—

(4211845) Urine protein measurement

232

1.64

2.22

3.6

3.8

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

421

3674

1.16

2.18

1.9

1.7

1.56

1.55

0.04

344

3095

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.24

2.17

1.4

—

7470.00

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

137

1072

1.29

2.14

1.7

1.8

2.85

9.78

iu/l

0.59

380

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

119

914

1.31

2.14

1.5

1.4

1522.14

985.93

e6/l

0.23

723

(44790047) Parainfluenza type 1 nucleic acid detection

612

1.38

2.14

1.7

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

612

1.38

2.14

1.7

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

612

1.38

2.14

1.7

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

612

1.38

2.14

1.7

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

298

1.55

2.13

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

664

1.36

2.12

1.7

1.6

0.85

0.86

g/l

0.04

511

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

315

1.53

2.10

1.2

1.1

—

(4146454) Self-monitoring of blood glucose

572

1.39

2.09

2.8

2.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

138

1.82

2.08

1.1

1.3

113.63

127.54

nmol/l

0.24

101

(3012898) Urea [Moles/volume] in Urine

2.56

2.07

1.2

127.00

155.09

mmol/l

0.53

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

5.00

2.07

5.2

3.7

2.19

1.84

g/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

464

1.43

2.07

1.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

523

1.40

2.06

1.3

1.4

169705.87

117864.99

e6/l

0.21

350

(3006462) Nitrate [Presence] in Urine

214

1.64

2.06

3.7

3.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

293

1.54

2.05

1.2

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

199

1.66

2.04

1.4

1.3

—

(3018333) Ribosomal P Ab [Presence] in Serum

278

1.55

2.02

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

483

1.41

2.02

2.1

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.05

2.00

1.1

1000.00

895.83

titre

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

255

1.57

2.00

2.0

2.2

23.00

209.31

ug/min

1.25

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

453

1.42

1.95

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

615

1.36

1.93

3.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

650

1.34

1.92

1.1

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

298

1.51

1.92

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

282

1.53

1.91

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.92

1.90

5.3

6.5

8.35

8.49

mmol/l

0.10

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

414

1.43

1.89

1.1

—

4.22

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.86

1.86

1.6

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

1.86

1.3

1.2

—

(3020650) Glucose [Presence] in Urine

129

1.79

1.85

1.5

1.8

0.00

0.05

estimate

0.80

129

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.53

1.83

35.0

6.3

110.67

106.41

g/l

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

198

1.62

1.83

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

138

1106

1.25

1.82

3.6

3.7

30.49

30.44

mg/l

0.00

796

(3042111) Morphology [Interpretation] in Bone marrow Narrative

128

1017

1.26

1.82

1.8

1.5

—

(3042517) Benzodiazepines panel - Urine

4.17

1.82

1.2

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

183

1.64

1.81

2.1

1.7

—

(21494815) CD4 cells/Lymphocytes in Specimen

327

1.47

1.80

2.0

35.97

38.39

0.48

320

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.05

1.80

1.9

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

512

1.37

1.79

2.1

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

165

0.42

1.78

1.0

1.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

168

0.42

1.77

1.0

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

172

1418

1.22

1.77

1.5

0.25

0.34

mg/l

1.61

621

(3038071) Oxygen [Partial pressure] in Mixed venous blood

102

1.87

1.75

16.4

6.7

5.77

5.25

kpa

0.39

102

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

354

1.44

1.75

1.9

1.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.90

1.75

1.3

1.2

80.10

83.02

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

147

1.70

1.73

1.1

1594.68

1497.16

miu/ml

0.13

147

(3026389) Candida sp identified in Specimen by Organism specific culture

628

1.33

1.72

1.3

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.85

1.71

1.0

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.85

1.71

2.0

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

282

1.49

1.71

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

282

1.49

1.71

1.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

163

1.66

1.71

1.1

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

348

1.44

1.70

1.5

1.2

2.50

2.26

mmol/l

0.29

320

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

350

1.43

1.66

1.0

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.86

1.65

1.3

90.27

84.67

0.35

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

181

1.61

1.63

2.1

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

181

1.61

1.63

2.1

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

181

1.61

1.63

1.8

2.1

70.13

127.31

umol/l

1.30

100

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

286

1.47

1.61

1.7

1.5

6.52

7.44

u/l

0.17

233

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.84

1.61

1.3

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.20

1.56

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

313

1.44

1.56

1.1

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

449

1.36

1.54

1.4

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

107

1.78

1.54

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

100

1.80

1.52

1.4

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

563

1.32

1.51

3.6

4.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

122

989

1.24

1.51

3.7

1.25

1.69

1.14

109

855

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

426

1.37

1.49

1.2

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

697

1.28

1.48

2.2

2.1

21.61

24.36

mg/l

0.23

238

(40768443) Skin Pathology biopsy report

251

2183

1.16

1.45

1.4

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

429

1.36

1.44

1.3

1.2

8.35

7.77

mmol/l

0.73

355

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.12

1.44

3.2

2.4

0.36

0.46

u/field

0.17

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.13

1.44

1.8

1.5

552.20

284.78

nmol/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

126

1.67

1.39

1.0

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

181

1.55

1.39

1.9

30.75

32.26

0.17

181

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1146

10822

1.07

1.39

3.5

0.82

ug/l

0.06

834

7715

(3024263) Appearance of Synovial fluid

263

1.45

1.38

1.9

1.6

—

(3011288) Drugs identified in Urine by Screen method Nominal

305

1.41

1.37

2.8

2.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

214

1.50

1.37

1.9

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

777

1.25

1.36

1.7

1.8

4.37

4.49

mmol/24h

0.15

665

(3020618) Glucose [Moles/volume] in Synovial fluid

2.94

1.36

1.0

1.1

7.78

5.09

mmol/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

323

1.40

1.35

4.9

5.8

31.55

77.30

u/ml

1.03

108

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

663

1.27

1.34

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

392

1.36

1.34

1.3

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

299

1.41

1.33

1.3

0.92

1.02

promille

0.19

237

(3009466) Valproate [Moles/volume] in Serum or Plasma

594

1.28

1.31

3.6

4.6

334.60

342.61

umol/l

0.16

509

(40768441) Liver Pathology biopsy report

300

1.40

1.30

1.4

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

591

0.73

1.30

1.1

1.2

0.52

0.62

ratio

1.14

107

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

420

1.34

1.30

1.2

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

219

0.55

1.29

1.3

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

499

1.31

1.29

1.2

110.10

55.79

u/ml

—

(4062490) Immunoglobulin typing, IgG

395

1.35

1.28

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

114

1.67

1.28

1.3

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

107

1.68

1.25

2.2

2.0

—

(3023410) Appearance of Cerebral spinal fluid

373

1.34

1.22

1.8

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.97

1.22

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.04

1.22

1.1

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

120

999

1.21

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.72

1.21

1.1

1.2

—

(4035726) Immunohistochemistry procedure

488

4478

1.10

1.20

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

400

1.33

1.20

1.2

1.3

6.23

7.03

g/l

0.93

288

(3028192) IgG subclass 2 [Mass/volume] in Serum

400

1.33

1.20

1.2

1.3

2.86

2.92

g/l

0.09

288

(3024139) IgG subclass 3 [Mass/volume] in Serum

400

1.33

1.20

1.2

1.3

0.37

0.44

g/l

1.17

288

(40757373) Influenza virus identified in Isolate

101

1.69

1.19

1.6

1.5

—

(3045142) Bone marrow Pathology biopsy report

621

1.26

1.19

1.2

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.31

1.18

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

649

1.25

1.17

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

173

1.51

1.17

1.0

1.2

42.93

40.47

g/l

0.53

(3016018) Differential panel - Cerebral spinal fluid

446

1.30

1.16

1.5

1.3

—

(3039000) Anion gap in Blood by calculation

138

1170

1.18

1.15

6.3

6.2

11.12

11.33

mmol/l

0.30

128

1043

(3018572) Chloride [Moles/volume] in Blood

138

1170

1.18

1.15

6.3

6.2

104.90

104.96

mmol/l

0.05

128

1043

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.05

1.15

1.1

0.04

0.03

u/ml

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

197

0.56

1.13

1.1

1.5

0.96

0.95

ratio

—

128

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

197

0.56

1.13

1.1

1.5

1.39

1.09

ratio

—

128

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

196

0.56

1.12

1.1

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

664

0.77

1.11

1.2

1.53

1.52

g/l

0.03

664

(3024522) Salmonella sp identified in Specimen by Organism specific culture

655

1.24

1.10

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

160

1.50

1.09

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.95

1.08

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.95

1.08

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.95

1.08

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.65

1.06

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

605

1.24

1.05

1.3

183.77

216.90

miu/ml

0.20

204

(40768800) Prostate Pathology biopsy report

113

1337

0.84

1.04

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

206

2329

0.88

1.04

2.1

3.23

3.44

ratio

2.22

172

1910

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.06

1.02

1.0

1.1

—

3.50

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

114

1.58

1.02

1.3

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

255

1.37

1.02

1.4

1.5

59.24

68.42

0.73

212

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.89

1.01

1.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.89

1.01

1.8

1.5

43.80

45.19

umol/l

—

(3028433) Virus identified in Specimen by Culture

139

1.51

1.00

1.3

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

343

1.31

0.99

2.4

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

133

0.53

0.98

21.6

13.0

741.57

803.29

nmol/l

—

126

(21494434) Karyotype in Bone marrow

503

1.26

0.98

1.3

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

2.17

0.98

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.1

—

0.16

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

285

1.34

0.94

1.9

1.7

81.63

90.40

umol/l

0.95

285

(3006922) Hepatitis E virus Ab [Presence] in Serum

268

1.35

0.94

1.1

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

347

1.30

0.93

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.72

0.92

1.1

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.82

0.92

1.7

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

218

1.38

0.91

1.6

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

118

1.53

0.90

1.2

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

253

1.35

0.90

3.7

3.3

0.68

1.36

3.89

253

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

167

1472

1.14

0.90

1.6

19.31

25.55

u/ml

0.56

251

(3008295) Osmolality of Serum or Plasma

582

1.22

0.89

1.3

273.40

275.29

mosm/kgh2o

0.20

429

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

298

1.31

0.87

3.7

3.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

631

1.21

0.86

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.82

0.85

1.6

1.7

—

(3016879) Cocaine [Presence] in Urine

415

1.26

0.84

2.5

1.9

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.59

0.84

1.4

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

353

1.28

0.84

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

362

1.27

0.84

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

633

1.20

0.83

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

188

1.38

0.82

1.4

1.3

—

(3027008) Opiates [Presence] in Urine

453

1.24

0.82

2.4

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.88

0.81

4.0

2.3

—

(3046861) Legionella sp Ag [Presence] in Urine

1.88

0.81

1.2

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.88

0.81

1.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

249

1.33

0.81

1.6

1.5

11.22

7.29

u/l

0.28

208

(3038177) Helicobacter pylori Ab [Presence] in Serum

526

1.22

0.81

1.2

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

191

1712

1.12

0.81

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

455

1.23

0.79

2.4

1.8

—

(3027944) Amphetamines [Presence] in Urine

446

1.24

0.79

2.5

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.67

0.78

1.3

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

629

1.20

0.78

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

115

1.48

0.76

1.2

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

1.44

0.75

1.1

—

(40762814) Titanium [Mass/volume] in Blood

1.54

0.75

2.9

2.3

2.45

3.49

ug/l

—

(3044007) Cell count panel - Peritoneal fluid

185

0.65

0.75

2.7

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

124

1.45

0.75

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

1.80

0.72

2.0

1.8

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.80

0.72

1.6

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

828

0.84

0.72

1.2

1.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.55

0.71

1.1

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

194

1.34

0.71

1.4

1.3

6.44

6.15

mmol/l

0.30

182

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

109

1.47

0.70

2.3

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

324

3009

1.08

0.69

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

401

4278

0.93

0.69

1.3

1.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

485

1.20

0.65

1.6

1.5

22.72

27.24

0.57

303

(3020393) Adenovirus Ag [Presence] in Stool

1.59

0.65

1.1

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.57

0.65

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

154

1.37

0.64

1.2

1.1

—

(4034850) Laboratory test

157

1416

1.11

0.64

14.2

11.7

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.72

0.64

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

129

1.40

0.63

1.0

1.5

74.67

502.30

nmol/24h

1.12

129

(1617658) Protocol used for examination of sentinel lymph nodes

303

0.76

0.63

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.52

0.62

1.3

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.59

0.61

2.3

1.9

—

(3028717) Thiamine [Mass/volume] in Blood

1.59

0.61

1.0

1.3

68.80

63.49

ug/l

—

(3000764) Benzodiazepines [Presence] in Urine

453

1.19

0.60

2.4

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.60

0.0

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

683

0.85

0.59

1.5

1.4

32.58

30.48

iu/l

0.16

577

(3001729) Color of Synovial fluid

1.54

0.59

1.4

1.6

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

2.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.56

0.58

1.2

2.3

0.55

0.63

ug/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.46

0.58

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

123

1.38

0.57

2.5

2.2

3.35

342.93

ug/l

0.82

123

(3017446) Testosterone [Moles/volume] in Serum or Plasma

377

3552

1.07

0.57

2.4

2.2

12.19

12.38

nmol/l

0.14

325

3126

(3020961) Endomysium IgA Ab [Titer] in Serum

175

1599

1.10

0.57

1.2

1.1

66.43

197.97

titre

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

106

1.42

0.57

1.8

1.7

10.11

9.28

ug/l

0.22

106

(40768793) Breast Pathology biopsy report

999

0.88

0.57

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.54

0.55

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

168

1.31

0.54

3.6

2.6

26.20

29.64

umol/l

0.62

124

(44806420) Estimation of glomerular filtration rate

358

1.20

0.53

2.7

2.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.45

0.53

1.3

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

134

1.34

0.53

1.2

1.1

15.00

24.71

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

150

1642

0.91

0.52

1.7

1.8

3.11

3.39

mmol/l

2.34

114

1207

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

480

1.17

0.51

1.2

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

296

1.22

0.51

1.1

1.00

0.98

u/ml

0.01

151

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.46

0.50

4.3

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

180

1.28

0.49

1.1

205.67

473.60

ng/l

—

(3035933) Granulocytes/Leukocytes in Blood

108

973

1.11

0.49

3.7

3.3

57.89

58.78

0.28

108

973

(3050794) Legionella sp Ab [Presence] in Serum

1.56

0.49

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.56

0.49

1.1

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.40

0.48

1.1

0.79

0.67

umol/24h

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

199

1.26

0.47

2.7

1.7

59.28

57.25

ug/l

0.07

191

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

392

1.17

0.46

1.9

2.0

8969.52

4592.30

u/l

0.20

152

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

366

1.18

0.45

1.0

276.10

309.72

ng/l

0.49

236

(3036048) Francisella tularensis Ab [Titer] in Serum

1.40

0.44

1.1

1.2

—

680.00

—

(40765096) Chromosome analysis panel by Banding

166

1.27

0.43

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.64

0.42

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

774

1.11

0.42

1.7

1.9

195.95

195.98

pmol/l

0.00

724

(3006270) Folate [Moles/volume] in Blood

444

1.15

0.41

1.2

324.90

328.89

nmol/l

0.05

346

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.52

0.41

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.41

0.0

3.9

—

42.40

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.41

0.0

7.7

—

9.33

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.11

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

0.01

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.47

0.40

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

150

1.27

0.40

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.43

0.39

1.0

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

214

1.22

0.39

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

108

989

1.09

0.39

1.6

1.8

45.84

44.22

nmol/l

0.29

102

946

(3023511) Choriogonadotropin [Units/volume] in Urine

142

1.27

0.38

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.39

0.38

1.0

1.1

—

(1002224) Polysomnography panel

134

1241

1.08

0.38

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

685

1.11

0.37

1.7

1.8

296.70

293.57

mu/l

0.04

636

(4094501) Cardiovascular stress test using bicycle ergometer

134

1243

1.08

0.37

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

227

2148

1.06

0.36

3.5

3.3

87.92

1871.95

u/ml

2.23

201

1852

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.43

0.35

1.2

1.9

13.20

17.65

umol/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

366

1.15

0.35

1.0

674.15

705.00

ng/l

0.20

228

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

366

1.15

0.35

1.0

32.11

41.23

ng/l

1.20

234

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

555

1.12

0.35

1.3

1.7

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.40

0.35

1.3

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

255

1.18

0.34

1.4

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.30

0.33

1.2

2.04

1.83

umol/24h

—

(3000060) B lymphocytes [#/volume] in Blood

1.33

0.32

3.1

1.7

3.37

1.75

e9/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

390

0.87

0.31

1.0

1.1

1.82

1.99

eliau/ml

0.09

120

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

258

1.16

0.31

1.4

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

193

1.19

0.30

1.9

1.5

18.63

12.60

ug/l

0.34

172

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

240

1.17

0.30

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

120

1.25

0.30

1.1

1.2

1.65

1.55

mmol/l

—

(3035880) pH of Pleural fluid

353

1.13

0.30

1.4

1.3

7.43

7.41

0.27

238

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

222

1.17

0.29

1.2

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

203

1931

1.05

0.29

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

316

1.14

0.29

2.3

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

184

0.81

0.28

1.3

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.29

0.28

1.5

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.25

0.27

1.4

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

233

1.16

0.27

1.7

1.6

8.95

10.03

umol/l

0.08

157

(3020491) Glucose [Moles/volume] in Blood

318

1.13

0.27

2.9

2.4

7.20

6.82

mmol/l

0.48

219

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.26

0.26

1.1

230.00

304.94

pmol/l

—

(44813793) Dust mix specific IgE antibody measurement

216

1.16

0.25

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

254

1.14

0.25

2.1

1.5

0.20

0.26

nmol/l

0.30

187

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

151

1.19

0.25

1.1

1.2

12.18

11.43

pmol/l

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

105

1.24

0.24

1.3

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

283

1.13

0.24

1.3

1.1

—

(3013727) Leukocytes other/Leukocytes in Blood

189

1.16

0.24

4.8

3.5

45.07

56.24

1.79

180

(3047007) Chlamydophila sp Ab [Presence] in Serum

423

0.90

0.24

1.2

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

152

1.18

0.23

4.9

5.7

62.92

70.38

0.44

117

(3023430) Cat dander IgE Ab [Units/volume] in Serum

254

0.87

0.23

1.1

4.04

2.08

u/ml

0.34

111

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

172

1.16

0.22

3.6

1.4

29.05

29.49

umol/l

0.08

159

(3052592) Norovirus Ag [Presence] in Stool

116

1.21

0.22

1.1

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.19

0.21

8.8

3.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

895

1.06

0.21

1.1

1.28

6.54

eliau/ml

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

1.93

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

103

0.78

0.21

1.9

1.5

41.70

53.97

ug/l

—

103

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

30.05

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.13

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.20

0.0

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.03

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

108

1.20

0.20

4.3

1.7

3.67

5.69

ug/l

0.31

(3014133) Dog dander IgE Ab [Units/volume] in Serum

271

0.89

0.20

1.1

3.96

1.86

u/ml

0.36

136

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.20

0.19

4.2

2.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

250

1.12

0.19

1.4

1.3

42.19

32.61

u/l

0.70

204

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.13

0.18

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

232

1.12

0.18

7.7

7.1

199.21

216.09

ug/l

0.03

146

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

204

1.13

0.18

1.2

1.4

134.77

198.35

pmol/l

0.67

204

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

668

1.06

0.17

1.5

1.8

—

(3034891) Synovial lining cells/cells in Synovial fluid

252

1.11

0.17

1.5

1.4

7.38

2.57

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.22

0.17

7.9

6.8

10.25

—

(4133840) Spirometry

0.76

0.15

1.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

145

1400

1.04

0.14

1.7

—

(3025577) Chromium [Mass/volume] in Blood

352

1.08

0.14

1.9

2.2

1.77

2.10

ug/l

0.46

294

(4281824) Cell count and differential, peritoneal fluid

502

0.94

0.14

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

604

0.94

0.14

1.4

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

237

1.10

0.14

1.8

341.11

303.45

mu/l

0.31

184

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

284

0.92

0.13

1.1

2.25

14.14

nmol/l

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

725

1.05

0.13

1.1

—

(3033099) Centromere Ab [Titer] in Serum

1.17

0.13

1.3

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

113

1.15

0.13

1.5

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

726

1.05

0.13

1.3

1.4

18.45

10.56

u/l

1.89

579

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

219

1.10

0.12

1.3

896.40

350.18

ug/l

0.28

105

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

121

1170

1.03

0.12

1.3

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

158

0.89

0.12

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

158

0.89

0.12

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

158

0.89

0.12

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

158

0.89

0.12

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

353

0.93

0.11

1.9

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

229

0.92

0.10

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

115

1.13

0.10

1.4

1.21

1.17

mmol/l

0.70

115

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.11

0.09

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.09

0.09

1.0

1.2

6.80

10.83

u/l

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.06

0.09

1.2

1.8

0.46

1.44

mmol/l

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.15

0.09

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

350

1.06

0.09

1.0

1.1

5.63

2.74

u/ml

0.35

169

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.83

0.08

1.0

1.1

—

(4198724) Urine methamphetamine measurement

1.09

0.08

1.3

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

104

1014

1.03

0.07

2.0

1.7

7.74

4.84

mg/l

0.59

757

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

111

0.90

0.06

1.1

1.4

17.30

11.14

mm/h

—

111

(3032057) Clostridioides difficile [Presence] in Stool

119

1.09

0.06

1.4

1.8

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

201

1983

1.01

0.05

3.4

4.3

42.20

103.06

u/ml

4.00

189

1902

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

129

1.09

0.05

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

395

1.04

0.05

1.1

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.11

0.05

3.4

1.1

17.62

15.69

umol/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

427

1.03

0.04

1.1

0.53

1.46

u/ml

2.13

238

(3048879) Bone marrow aspiration report

160

1.06

0.04

2.2

1.6

—

2.00

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

1.07

0.03

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

152

1.05

0.02

1.4

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

208

0.96

0.02

1.7

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

137

0.95

0.01

1.8

1.6

0.26

0.37

ug/l

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

143

1.05

0.01

1.4

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

114

1.05

0.00

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

124

1.05

0.00

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

816

0.99

0.00

2.6

2.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

944

1.01

0.00

1.5

1.7

—

(4015189) Microbial culture of sputum

162

0.99

0.00

1.8

2.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

154

1538

1.00

0.00

1.8

1.7

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

106

1.04

0.00

1.3

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

226

1.02

0.00

1.0

1.1

2.16

0.14

u/ml

1.10

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

274

0.99

0.00

1.3

0.76

1.19

u/ml

0.38

163

(40768795) Lymph node Pathology biopsy report

486

1.01

0.00

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

343

0.99

0.00

1.0

1.1

1.04

1.18

u/ml

0.06

140

(3003740) Influenza virus B Ag [Presence] in Specimen

397

1.01

0.00

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

122

1223

1.00

0.00

3.1

3.3

223.34

965.83

u/ml

1.96

109

1118

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

241

1.00

0.00

2.5

1.7

38.75

39.75

g/l

0.46

241

(3025130) Human papilloma virus identified in Specimen

311

1.00

0.00

2.0

1.7

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.00

-0.00

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

-0.00

0.0

2.0

—

13.10

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

442.17

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

3.25

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.4

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

-0.00

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.98

-0.00

2.8

12.5

0.20

0.24

—

(3039443) Prostate specific Ag panel - Serum or Plasma

660

1.00

-0.00

1.6

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.2

—

1.40

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.91

-0.00

1.2

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_RETIVASCOCCLUSION and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_RETIVASCOCCLUSION	1.174 [1.08, 1.28]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.142

During the follow-up period (1.1.1998 — 31.12.2019), 5754 out of 16475 females with H7_RETIVASCOCCLUSION died.

Males

Parameter	HR [95% CI]	p-value
H7_RETIVASCOCCLUSION	1.288 [1.17, 1.41]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 5940 out of 16228 males with H7_RETIVASCOCCLUSION died.

Mortality risk

Mortality risk for people of age

years, who have H7_RETIVASCOCCLUSION.

N-year risk	Females	Males
1	0.074%	0.199%
5	0.61%	1.392%
10	1.777%	3.547%
15	3.236%	6.767%
20	5.594%	11.494%

Relationships between endpoints

↥

Index endpoint: H7_RETIVASCOCCLUSION – Retinal vascular occlusion

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Retinal vascular occlusion

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints